Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3001334	s-anca	— (—)	11001	14062	100.00%	Distribution not available
3001334	s-anca-t	— (—)	4223	5070	100.00%	Distribution not available
3001334	s-ancaab	— (—)	620	917	100.00%	Distribution not available
3001334	s-ancatut	— (—)	488	579	100.00%	Distribution not available
3001334	s-ancabk	— (—)	394	422	100.00%	Distribution not available
3001334	s-ancak	— (—)	246	258	100.00%	Distribution not available
3001334	s-ancapika	— (—)	99	100	100.00%	Distribution not available
3001334	s-ancapik	— (—)	22	24	100.00%	Distribution not available
3001334	s-ancab	— (—)	11	11	100.00%	Distribution not available
3001334	s.anca-t	— (—)	6	6	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Erysipelas, including avohilmo

2669

8739

2.34

323.31

1.3

—

Cholangitis (primary sclerosing, PSC)

513

813

7.53

320.08

2.3

1.2

—

COPD/asthma/ILD related infections

3370

7907

2.19

319.48

1.3

1.2

—

COPD/asthma related infections

3370

7907

2.19

319.48

1.3

1.2

—

Chronic lower respiratory diseases

4216

11439

1.99

315.88

1.3

—

Giant cell arteritis

396

481

10.53

315.66

1.6

1.1

—

Abnormal findings on examination of blood, without diagnosis

2049

7550

2.58

314.97

1.4

1.3

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

1021

1810

4.14

314.09

1.2

1.3

—

Other specific joint derangements/joint disorders

2644

7258

2.34

308.88

1.3

—

Heart failure,strict

2293

5537

3.06

307.65

1.2

1.3

—

Unspecified kidney failure

658

1290

5.74

307.65

1.3

1.2

—

Nephropathy related operations

824

1803

5.24

307.65

1.4

1.2

—

Other necrotizing vasculopathies (FG)

848

623

19.95

307.65

2.8

1.1

—

Interstitial lung disease endpoints

1369

2228

7.41

307.65

1.3

—

Abnormalities of breathing

3476

7766

2.65

307.65

1.3

—

Renal failure

3200

6257

4.83

307.65

1.3

—

Implicit Sepsis, including avohilmo

3477

9888

2.62

307.65

1.3

—

Other bacterial diseases

4261

10285

2.88

307.65

1.3

—

Polyarthropathies

3143

6645

3.20

307.65

1.3

—

1934

7231

2.78

307.65

1.4

1.3

—

General symptoms and signs

4038

7922

2.64

307.65

1.3

—

Asthma-related infections

2587

9908

2.66

307.65

1.4

1.3

—

Other diseases of pleura

1987

6652

2.74

307.65

1.5

1.2

—

Vasculitis limited to skin, not elsewhere classified

417

327

20.64

307.65

1.5

1.2

—

Used for control exclusion in common control thyroid runs

3951

8128

2.53

307.65

1.4

1.1

—

All chronic kidney diseases

3438

6593

4.54

307.65

1.4

1.3

—

Polyneuropathies and other disorders of the peripheral nervous system

1299

3431

4.19

307.65

1.3

—

Examination and observation for other reasons

2233

4673

2.80

307.65

1.4

1.2

—

Influenza and pneumonia

4378

10878

2.58

307.65

1.3

—

Autoimmune diseases

4348

8804

2.60

307.65

1.5

1.1

—

Interstitial lung disease

1369

2228

7.41

307.65

1.3

—

Reimbursement for rheumatic diseases

3126

9107

3.67

307.65

1.7

1.2

—

All pneumoniae

4301

11092

2.62

307.65

1.3

—

GASTRO-related operations

2608

4750

2.84

307.65

1.4

1.2

—

Other and unspecified polyneuropathies, also in other diseases

1210

2979

4.55

307.65

1.3

—

Autoimmune diseases excluding thyroid diseases

4744

8755

3.08

307.65

1.5

1.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3809

7907

2.94

307.65

1.3

1.2

—

Other respiratory diseases principally affecting the interstitium

1546

2598

7.07

307.65

1.4

1.2

—

Bacterial infection, other or unspecified

2900

7013

3.75

307.65

1.4

1.3

—

All kidney diseases

4551

10567

3.03

307.65

1.3

—

Malaise and fatigue

2050

5787

2.91

307.65

1.3

1.2

—

Other anaemias

1911

6840

2.76

307.65

1.3

—

Cardiovascular diseases (excluding rheumatic etc)

2159

4638

2.75

307.65

1.3

—

Glomerular disorders in diseases classified elsewhere

976

1639

7.12

307.65

1.7

1.2

—

Other pulmonary diagnosis

2578

4725

2.82

307.65

1.3

1.2

—

Certain disorders involving the immune mechanism

1074

2906

4.07

307.65

1.4

1.3

—

Asthma (only as main-diagnosis), excluding more controls

2759

4198

3.80

307.65

1.4

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3437

9993

2.48

307.65

1.3

—

Bacterial Sepsis

2392

6328

3.33

307.65

1.3

—

Systemic connective tissue disorders

2816

5112

6.34

307.65

1.8

1.2

—

Asthma, excluding more controls

2930

4198

3.75

307.65

1.3

1.2

—

5-aminosalicylic acid

925

2250

4.39

307.65

1.7

1.1

—

Other septicaemia, including avohilmo

1683

5374

3.10

307.65

1.4

1.3

—

Certain infectious and parasitic diseases

3212

7309

2.26

307.65

1.3

1.2

—

Acute renal failure

1465

3137

5.24

307.65

1.4

1.2

—

ILD, hospital admissions 1, main diag only

1263

1957

7.92

307.65

1.4

1.2

—

Other interstitial pulmonary diseases

1369

2197

7.52

307.65

1.3

1.2

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

330

205

28.31

307.65

2.7

1.1

—

Anaemias

1058

1174

6.17

307.65

1.4

1.3

—

ILD medications: immunosuppressive drugs

4124

6899

5.93

307.65

1.6

1.1

—

Infections, IBD-co-morbidities

681

718

7.12

307.65

1.4

1.2

—

ILD medications: azathioprine

1026

1360

8.62

307.65

2.1

1.2

—

Heart failure, not strict

3343

7842

3.03

307.65

1.3

—

Oedema, not elsewhere classified

1399

4321

3.34

307.65

1.3

1.2

—

All-cause Heart Failure

2405

6699

2.62

307.65

1.2

1.3

—

Wegener granulomatosis

303

157

39.61

307.65

4.2

1.1

—

Asthma

3024

4681

3.48

307.65

1.3

1.2

—

Other heart diseases

1705

3736

3.09

307.65

1.3

—

Heart failure, strict

2455

6788

2.64

307.65

1.2

1.3

—

Other necrotizing vasculopathies

951

867

15.67

307.65

2.7

1.1

—

Other and unspecified anaemias

1898

6798

2.76

307.65

1.3

—

Oral corticosteroids

6312

8261

4.82

307.65

1.5

1.1

—

Asthma (only as main-diagnosis)

2829

4681

3.53

307.65

1.4

1.2

—

Second line medication for Crohn's disease

3291

9370

3.79

307.65

1.6

1.2

—

Renal tubulo-interstitial diseases

4136

10405

3.07

307.65

1.3

—

Other soft tissue disorders, not elsewhere classified

3386

9079

2.19

307.65

1.3

—

Abnormal findings on diagnostic imaging of lung

2708

7456

3.72

307.65

1.4

1.3

—

Other bacterial diseases, including avohilmo

4292

10376

2.69

307.65

1.3

—

Dyspnoea

3794

11347

2.51

307.65

1.3

—

Any gastric operation

2608

4750

2.84

307.65

1.4

1.2

—

Dermatitis

2545

10791

2.40

307.65

1.3

—

Asthma-related pneumonia or sepsis

1635

5895

2.92

307.65

1.4

1.3

—

ILD, hospital admissions 3, with pneumonia sepsis

775

1003

9.45

307.65

1.4

1.2

—

ILD, hospital admissions

1358

2201

7.47

307.65

1.3

1.2

—

Implicit bacterial Sepsis, including avohilmo

2332

6161

3.36

307.65

1.3

—

Explicit Sepsis

1917

6384

2.88

307.65

1.3

—

Implicit viral Sepsis, including avohilmo

1405

4645

3.21

307.65

1.4

1.3

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

681

1012

8.17

307.65

1.5

1.2

—

Asthma, hospital admissions 3, pneumonia

1635

5895

2.92

307.65

1.4

1.3

—

Asthma (mode)

2949

4732

3.41

307.65

1.3

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

4307

11059

2.65

307.65

1.3

—

Colitis, primary sclerosing

283

182

30.86

307.65

2.8

1.3

—

Chronic kidney disease

2350

4454

5.75

307.65

1.3

—

Other arthritis (FG)

1501

4129

3.89

307.65

1.4

1.2

—

Excluding asthma or asthma-COPD overlap

2565

4725

2.81

307.65

1.3

1.2

—

Tramadol

3062

7521

2.54

307.65

1.3

—

Inflammatory bowel disease treatment related agents

6460

8442

4.54

307.65

1.5

1.1

—

COPD differential diagnosis

2555

4733

2.79

307.65

1.3

1.2

—

Heart failure and antihypertensive medication

1138

1830

4.33

307.65

1.2

—

3809

7907

2.94

307.65

1.3

1.2

—

ILD, hospital admission 2, with pulmonary infections

922

1140

9.91

307.65

1.4

1.2

—

ILD differential diagnosis

2553

4732

2.79

307.65

1.3

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

4587

8526

3.06

307.65

1.5

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

6164

7483

4.91

307.65

1.4

1.1

—

Azathioprine

1026

1476

7.93

307.65

2.1

1.2

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1158

459

21.96

307.65

1.3

1.1

—

Septicaemia

1857

5764

3.10

307.65

1.3

—

Aplastic and other anaemias

2065

7212

2.76

307.65

1.3

—

Other systemic involvement of connective tissue (FG)

1730

3119

6.09

307.65

1.4

1.2

—

Pneumonia, organism unspecified

4031

10376

2.79

307.65

1.3

—

Care involving dialysis

605

1065

6.69

307.65

1.4

1.3

—

Dialysis, with operation codes

886

1645

6.22

307.65

1.4

1.2

—

Other specified/unspecified arthritis

1316

3832

3.68

307.65

1.4

1.3

—

Autoimmune diseases related-to ILD

4253

11072

3.40

307.65

1.7

1.2

—

IBD (strict) with PSC

236

122

48.21

307.65

2.9

1.3

—

Other septicaemia

1657

5266

3.13

307.65

1.4

1.3

—

Implicit bacterial Sepsis

2160

5720

3.47

307.65

1.3

—

Asthma, hospital admission 2, infections

2587

9908

2.66

307.65

1.4

1.3

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3457

9727

3.30

307.65

1.4

1.3

—

L04AA Selective immunosuppressants

1325

3395

4.31

307.65

1.6

1.3

—

Asthma (diagnoses ohter than nonallergic)

3393

12775

2.22

307.65

1.3

—

Other and unspecified vasculitis limited to skin

380

289

21.51

307.65

1.5

1.2

—

Polymyalgia rheumatica

853

1764

5.47

307.65

1.3

1.1

—

Bacterial infection, other or unspecified, including avohilmo

3094

7497

3.62

307.65

1.4

1.3

—

Asthma, unspecified (mode)

2179

4426

3.72

307.65

1.3

1.2

—

Asthma, unspecified (mode), excluding more controls

2129

3965

4.04

307.65

1.3

1.2

—

Asthma-related pneumonia

1634

5885

2.92

307.65

1.4

1.3

—

Pain in joint

2235

5445

2.61

307.65

1.3

—

Idiopathic pulmonary fibrosis

575

1004

6.75

307.65

1.3

1.2

—

Haemorrhage from respiratory passages

1494

4366

3.19

307.65

1.3

—

First line medication for Crohn's disease

5752

7460

4.41

307.65

1.4

1.1

—

ILD medications

6226

7566

4.74

307.65

1.4

1.1

—

Fever of other and unknown origin

3233

6879

4.38

307.65

1.4

1.3

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4220

11152

2.63

307.65

1.3

—

Finngen Rheumatological endpoints

3584

8281

2.54

307.65

1.4

1.2

—

L04AX Other immunosuppressants

3198

9124

3.79

307.65

1.6

1.2

—

Other and unspecified dermatitis

2200

9046

2.54

307.65

1.4

1.3

—

Headache

2294

7307

2.50

307.65

1.3

—

Other disorders of skin and subcutaneous tissue

2871

11074

2.27

307.65

1.3

—

Primary Sclerosing Cholangitis, IBD and UDCA required

399

252

27.91

307.65

2.7

1.2

—

Explicit Sepsis, including avohilmo

1951

6500

2.86

307.65

1.3

—

Implicit Sepsis

3332

9377

2.74

307.65

1.3

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3504

10228

2.40

307.65

1.3

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4897

10667

3.27

307.65

1.3

—

Glomerular diseases

1407

2672

6.13

307.65

1.6

1.3

—

Other systemic involvement of connective tissue

1770

3927

5.02

307.65

1.4

1.2

—

Cardiovascular diseases

1963

3878

2.77

307.63

1.3

—

Glomerulonephritis

659

1364

5.54

307.47

1.6

1.2

—

Gout

1263

3435

3.36

306.49

1.3

—

Medical observation and evaluation for suspected diseases and conditions

2283

4699

2.56

304.53

1.3

1.2

—

Noninfective enteritis and colitis

1925

7797

2.58

303.47

1.5

1.3

—

Ulcer of lower limb, not elsewhere classified

847

2153

4.36

302.12

1.3

1.2

—

Hypertensive diseases (excluding secondary)

1758

3688

2.88

301.69

1.3

—

Undetermined asthma, excluding more controls

605

1164

5.60

300.69

1.5

1.2

—

Pain in limb

2983

8915

2.19

299.48

1.3

—

Asthma, hospital admissions , main diagnosis only

3035

12861

2.12

298.20

1.4

1.3

—

Viral Sepsis

1030

3017

3.67

295.86

1.4

1.3

—

Implicit viral Sepsis

1028

3013

3.67

295.00

1.4

1.3

—

Symptoms and signs involving the circulatory and respiratory systems

3255

7783

2.15

294.47

1.3

—

Any reimbursement code in KELA

1751

3127

2.89

290.44

1.4

1.2

—

Colitis, primary sclerosing, strict definition

226

140

34.15

289.99

2.8

1.3

—

Cough

1583

5553

2.78

286.41

1.4

1.3

—

Erysipelas

2067

7558

2.45

285.24

1.3

—

Codeine

3091

8029

2.14

280.84

1.3

—

Undetermined asthma

605

1238

5.26

280.31

1.5

1.2

—

Other heart diseases, wide

3097

9186

2.10

275.81

1.3

—

Pain in throat and chest

2752

7640

2.19

272.37

1.3

—

Opioids

3202

8129

2.09

270.76

1.3

—

Ulcerative colitis (strict) with PSC

192

49.07

270.47

2.8

1.4

—

Dermatitis and eczema

3889

12437

1.90

261.06

1.3

—

Gout, FINNGEN

1263

4471

2.98

258.99

1.3

1.2

—

Diseases of arteries, arterioles and capillaries

2498

8658

2.19

257.94

1.3

—

Secondary hypertension

447

740

6.61

257.38

1.5

1.2

—

Coagulation defects, purpura and other haemorrhagic conditions

969

3007

3.48

254.76

1.4

1.3

—

Cerebrovascular diseases (FINNGEN)

1114

2481

3.29

251.95

1.2

1.3

—

Temporal arteritis

327

414

9.98

251.66

1.6

1.1

—

Inflammatory bowel disease

1341

5011

2.82

251.06

1.6

1.3

—

Diseases of liver

1477

5809

2.68

249.85

1.4

1.3

—

Bleeding

2972

10589

2.03

249.28

1.3

—

Chronic sinusitis

1647

6794

2.52

249.25

1.4

1.3

—

Other specified/unspecified systemic involvement of connective tissue

398

628

7.42

248.35

1.5

1.1

—

Sulfasalazine

1004

3212

3.28

247.54

1.3

1.1

—

Rheumatoid arthritis

1253

3974

2.93

246.36

1.4

1.3

—

3754

10248

1.90

244.30

1.4

1.3

—

Asthma, including avohilmo

3992

12166

1.85

243.74

1.3

—

Budesonide

613

1429

4.60

242.38

1.5

1.2

—

Diseases of oesophagus, stomach and duodenum

3597

11495

1.89

239.74

1.3

—

Acute tubulo-interstitial nephritis

2141

8356

2.23

239.37

1.3

—

Asthma/COPD (KELA code 203)

3233

11419

1.94

238.17

1.3

—

Codeine or tramadol medication

3767

11229

1.87

235.59

1.3

—

Heart failure and coronary heart disease

1690

4906

2.53

235.55

1.3

—

COPD (mode)

1015

2526

3.27

235.10

1.2

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1001

1428

3.61

234.82

1.3

1.2

—

Pain, not elsewhere classified

1060

3619

3.07

233.58

1.3

—

L04AD Calcineurin inhibitors

634

1578

4.49

233.57

1.5

1.3

—

Eosinophilic disease (BM)

180

102

24.57

231.82

1.6

1.1

—

Iron deficiency anaemia

1706

7248

2.41

231.65

1.4

1.3

—

IBD patients in KELA-register

1011

3395

3.16

231.24

1.7

1.3

—

Metabolic disorders

3183

10070

1.94

230.61

1.3

—

Non-allergic asthma (mode), excluding more controls

669

1704

4.09

229.83

1.3

1.2

—

Heart failure and bmi 25plus

1410

3596

2.76

228.98

1.2

1.3

—

Other specified/unspecified necrotizing vasculopathies

194

136

22.16

227.48

3.0

1.1

—

Extracorporeal dialysis

444

854

6.14

227.03

1.4

1.3

—

Microscopic polyangiitis

149

71.68

226.31

4.1

1.2

—

Nutritional anaemias

1906

8318

2.27

225.08

1.3

—

Obesity related asthma

1388

5567

2.62

224.80

1.3

—

Diseases of the skin and subcutaneous tissue

3106

8098

1.97

223.75

1.3

—

Persons encountering health services for specific procedures and health care

3564

11611

1.85

223.09

1.3

—

Giant cell arteritis with polymyalgia rheumatica

327

482

8.53

220.83

1.6

1.1

—

Inflammatory bowel disease, strict (require KELA)

1011

3499

3.07

219.21

1.7

1.3

—

Other and unspecified iron deficiency

1395

5676

2.57

218.08

1.4

1.3

—

Diseases of the respiratory system

1863

3992

2.40

217.41

1.3

1.2

—

Ulcerative colitis

1045

3715

2.98

215.49

1.7

1.3

—

Diagnoses used for exclusion with ILD

1111

4116

2.86

212.30

1.3

—

Enlarged lymph nodes

675

1877

3.83

209.05

1.2

1.3

—

Certain infectious and parasitic diseases, including avohilmo

2154

5005

2.21

208.88

1.3

1.2

—

Hypertension, essential

2437

6820

2.07

207.84

1.3

—

Provisional assignment of new diseases of uncertain etiology

1970

9376

2.16

207.27

1.4

1.3

—

Gout, idiopatic and unspecified

1108

4157

2.84

207.22

1.3

1.2

—

Codes for special purposes

1972

9391

2.16

207.10

1.4

1.3

—

Hypertensive diseases

2479

6993

2.05

205.56

1.3

—

Hypertension

2475

6985

2.05

204.87

1.3

—

Non-allergic asthma (mode)

669

1849

3.76

204.43

1.3

1.2

—

Disorders of thyroid, IBD co-morbidities

535

785

4.85

202.92

1.3

1.2

—

Neurological diseases, wide definition

806

1107

3.76

199.59

1.2

1.3

—

Bronchitis

3595

12395

1.78

197.45

1.4

1.3

—

Gout, unspecified

937

3306

3.03

197.34

1.3

1.2

—

Ulcerative colitis, NAS

672

1949

3.72

196.69

1.7

1.3

—

Non-ischemic cardiomyopathy

1204

3746

2.68

194.11

1.2

1.3

—

Suggestive for eosinophilic asthma

508

1229

4.59

194.00

1.5

1.3

—

Other disorders involving the immune mechanism, not elsewhere classified

282

407

8.64

193.79

1.5

1.3

—

Hard cardiovascular diseases

2711

8489

1.94

193.39

1.3

—

Biological medicines for asthma

231

265

11.41

193.37

1.4

1.2

—

Respiratory disorders in diseases classified elsewhere

191

173

16.87

192.58

3.1

1.2

—

Purpura and other haemorrhagic conditions

674

1997

3.66

191.39

1.4

1.3

—

Low back pain

2566

9144

1.94

190.40

1.3

—

Complications of surgical and medical care, not elsewhere classified

3295

12545

1.79

190.12

1.3

—

Symptoms and signs involving the skin and subcutaneous tissue

2493

12607

1.92

189.38

1.3

—

Covid-19 confirmed case

1451

6417

2.36

188.11

1.4

1.3

—

Hypertensive heart and/or renal disease

1011

2657

2.92

188.07

1.2

1.3

—

Rheumatoid arthritis, including avohilmo

1414

6219

2.37

186.39

1.4

1.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3172

11336

1.81

186.28

1.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1974

4699

2.18

186.19

1.3

1.2

—

Gout, strict definition

846

2920

3.11

185.77

1.3

1.2

—

Mucosal proctocolitis

621

1778

3.78

185.49

1.8

1.3

—

Bacterial pneumoniae

1413

5399

2.38

184.85

1.4

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1314

3355

2.54

184.52

1.4

1.3

—

Other disorders of fluid, electrolyte and acid-base balance

1220

4730

2.54

184.41

1.3

—

Seropositive rheumatoid arthritis

876

3054

2.99

184.17

1.4

1.2

—

SLE (Finngen)

244

316

9.09

181.96

1.4

1.1

—

Early onset COPD, excluding more controls

661

1976

3.50

181.80

1.3

1.2

—

Antihypertensive medication - note that there are other indications

1771

4216

2.25

181.51

1.3

—

Polyarteritis nodosa and related conditions

173

146

16.95

180.77

2.5

1.1

—

Continuous positive airway pressure

713

1821

3.43

180.42

1.3

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1204

5002

2.51

180.16

1.5

1.3

—

Oxycodone

1393

5204

2.37

179.73

1.3

—

Osteopathies and chondropathies

1993

9210

2.04

179.18

1.4

1.3

—

Dorsalgia

3121

9344

1.81

176.38

1.3

—

Bacterial pneumonia, not elsewhere classified

1335

5082

2.39

176.28

1.4

1.3

—

Other diseases of intestines

3311

10658

1.77

175.43

1.3

—

Cardiac arrhythmias

1805

5517

2.15

175.14

1.3

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

259

382

8.42

174.47

1.5

1.2

—

Sicca syndrome [Sjögren]

430

993

4.79

174.13

1.3

1.1

—

Biological medication for rheuma

776

2646

3.12

173.22

1.4

1.3

—

Other diseases of pericardium

297

501

6.83

173.18

1.3

1.2

—

Allergic asthma (mode), excluding more controls

703

2185

3.25

172.79

1.4

1.3

—

STROKE

1769

5700

2.15

172.74

1.2

1.3

—

Pleural effusion

700

2268

3.31

171.32

1.3

1.2

—

Other acute lower respiratory infections

1891

9105

2.04

170.99

1.4

1.3

—

Persons encountering health services in other circumstances, wide

3622

11055

1.72

170.97

1.3

—

Transplanted organ and tissue status

502

1325

4.16

169.81

1.5

1.3

—

Acute sinusitis

1772

7973

2.08

168.38

1.4

1.3

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

653

2068

3.39

166.05

1.3

—

Urticaria and erythema

1321

5921

2.32

165.97

1.3

—

Atrial fibrillation and flutter

963

2283

2.82

165.34

1.3

—

Spondylopathies

2525

8139

1.88

165.02

1.3

—

ILD-related respiratory insufficiency

260

408

7.73

164.61

1.5

1.2

—

Non-rheumatic valve diseases

1530

5073

2.22

163.57

1.3

—

Vocal cord dysfunction

446

938

4.38

162.94

1.3

1.1

—

Intestinal infectious diseases

3053

13324

1.74

162.79

1.3

—

Type 2 diabetes, wide definition

2533

8805

1.86

162.34

1.3

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

707

2380

3.16

161.59

1.8

1.3

—

Diseases of the musculoskeletal system and connective tissue

1489

3304

2.31

161.06

1.3

1.2

—

Valvular heart disease excluding rheumatic fever

1531

5114

2.21

161.00

1.3

—

Other diseases of blood and blood-forming organs, wide

915

3543

2.73

160.52

1.4

1.3

—

Arthropathies

2662

7434

1.84

159.53

1.3

—

Allergic asthma (mode)

703

2291

3.10

159.45

1.4

1.3

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3464

11033

1.70

159.20

1.3

—

Bacterial pneumonia (organism specified)

1560

6826

2.14

158.67

1.4

1.3

—

Dental caries

981

3692

2.62

158.62

1.3

—

Ulcerative colitis (strict definition, require KELA)

716

2457

3.10

158.08

1.8

1.3

—

Preparatory care for dialysis

313

613

6.04

157.23

1.5

1.2

—

Later onset COPD, excluding more controls

673

1627

3.30

157.02

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

2320

11484

1.85

155.92

1.3

—

Systemic lupus erythematosus

244

380

7.53

154.42

1.4

1.1

—

Syncope and collapse

1378

5310

2.23

154.30

1.2

1.3

—

Lower back pain or/and sciatica

3404

12872

1.68

153.22

1.3

—

Other joint disorders

2564

7420

1.84

152.87

1.3

—

Atrial fibrillation and flutter with reimbursement

808

1767

3.00

152.86

1.3

1.2

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

743

2659

2.96

151.76

1.8

1.3

—

Other disorders of white blood cells

342

740

5.28

151.72

1.5

1.2

—

Parasetamol

2079

5441

1.97

151.53

1.3

—

Gastrointestinal diseases

1659

3952

2.15

151.53

1.3

1.2

—

Complications of medical and surgical care

2418

12315

1.81

151.42

1.3

—

Nephrotic syndrome

237

371

7.69

150.18

1.4

1.2

—

Nerve, nerve root and plexus disorders

3344

12227

1.67

149.09

1.3

—

Crohn disease

578

1814

3.41

149.09

1.7

1.3

—

Soft tissue disorders

3041

9151

1.73

148.81

1.3

—

Caries of dentine

882

3334

2.67

148.68

1.3

—

Diabetic nephropathy, excluding more controls

697

1942

3.15

148.42

1.3

—

Acute bronchitis

1443

6849

2.13

148.36

1.4

1.3

—

Chronic ulcer of skin, not elsewhere classified

378

897

4.68

148.20

1.4

1.2

—

Sarcoidosis

597

1926

3.34

147.62

1.3

—

Insulin medication

2010

8970

1.91

147.51

1.3

—

Eosinophilia

181

218

11.36

147.09

1.6

1.3

—

General examination and investigation of persons without complaint and reported diagnosis

1809

4695

2.04

146.62

1.4

1.2

—

Disorders of gallbladder, biliary tract and pancreas

3111

11658

1.69

145.91

1.4

1.3

—

Percutaneous Coronary Intervention

2448

8391

1.82

144.90

1.3

—

Allergic purpura

229

361

7.56

143.88

1.5

1.3

—

Neurological diseases

2451

6850

1.83

143.38

1.3

—

Acute upper respiratory infections

3228

11797

1.67

142.84

1.4

1.3

—

Ischemic heart diseases

2545

8667

1.79

142.52

1.3

—

Disorders of sclera, cornea, iris and ciliary body

1852

9923

1.92

142.43

1.3

—

Other noninfective gastroenteritis and colitis

929

3821

2.54

142.43

1.4

1.3

—

Symptoms and signs involving the urinary system

2463

10709

1.78

141.01

1.3

—

Disorders of lipoprotein metabolism and other lipidaemias

2548

8930

1.77

139.40

1.3

—

Coronary revascularization (ANGIO or CABG)

2430

8399

1.80

139.26

1.3

—

Myalgia

855

3419

2.61

139.07

1.3

—

Sleep apnoea

2978

11334

1.69

138.82

1.3

—

Peripheral artery disease

1470

5725

2.10

138.34

1.2

1.3

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1396

5304

2.14

138.19

1.2

1.3

—

Hernia of abdominal wall, postoperative

590

1931

3.16

138.01

1.3

1.2

—

Respiratory insufficiency

321

698

4.90

137.99

1.3

1.2

—

Hypothyroidism (congenital or acquired)

677

1226

3.18

137.41

1.3

—

Emergency coronary revascularization (for ACS)

2630

9275

1.75

137.32

1.3

—

All influenza

889

3640

2.54

137.26

1.3

—

Disturbances of skin sensation

1001

4330

2.41

137.16

1.2

1.3

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1675

8461

1.96

136.74

1.4

1.3

—

Hypothyroidism and >3 levothyroxin purchases

671

1214

3.18

136.67

1.3

—

Hypothyroidism, levothyroxine purchases

671

1214

3.18

136.67

1.3

—

Other diseases of liver

744

2820

2.79

136.23

1.4

1.3

—

Intestinal infectious diseases, including avohilmo, including avohilmo

3520

12326

1.62

135.55

1.3

—

Major coronary heart disease event

2573

8970

1.75

135.24

1.3

—

Complications of procedures, not elsewhere classified

2557

12189

1.73

134.62

1.3

—

Abnormalities of heart beat

1112

4887

2.27

134.46

1.3

—

Small fibre neuropathy

232

401

6.99

133.67

1.4

1.2

—

Gastro-oesophageal reflux disease

2158

10317

1.81

133.63

1.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

2010

10170

1.84

133.24

1.3

—

Other disorders of lacrimal gland

1284

6224

2.14

132.47

1.4

1.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

1912

10578

1.86

132.46

1.3

—

Infections of the skin and subcutaneous tissue

1943

10625

1.85

132.12

1.3

—

Other diseases of upper respiratory tract

3274

10570

1.64

131.77

1.3

—

COPD

1466

5983

2.05

131.49

1.2

1.3

—

Implicit fungal Sepsis, including avohilmo

359

901

4.37

130.27

1.4

1.2

—

Endocrine, nutritional and metabolic diseases

2202

6169

1.83

130.16

1.3

—

Osteoporosis

971

3873

2.41

130.11

1.4

1.3

—

IgA nephropathy (IgA glomerulonephritis)

198

302

8.08

129.27

1.4

1.3

—

Other dorsopathies, not elsewhere classified

2965

9363

1.67

128.43

1.3

—

Pain (limb, back, neck, head abdominally)

2054

5610

1.87

128.37

1.3

—

SLE, strict definition

232

417

6.52

127.51

1.4

1.2

—

SLE, ICD10

232

417

6.52

127.51

1.4

1.2

—

Hypertensive Heart Disease

828

2513

2.60

126.51

1.2

1.3

—

Tumor necrosis factor alpha inhibitors

643

2351

2.89

126.16

1.4

1.3

—

Acute upper respiratory infections of multiple and unspecified sites

2356

10072

1.74

126.03

1.4

1.3

—

Disorders of lacrimal system

1486

7586

1.99

125.78

1.4

1.3

—

Venous thromboembolism

1764

9318

1.87

125.12

1.4

1.3

—

Hypothyroidism, strict autoimmune

1954

7082

1.84

124.94

1.3

1.1

—

Other diseases of the respiratory system

782

3168

2.59

124.57

1.4

1.3

—

Other respiratory disorders and diseases

782

3168

2.59

124.57

1.4

1.3

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1822

7857

1.87

123.89

1.2

1.3

—

Symptoms and signs involving the digestive system and abdomen

2943

9032

1.66

122.93

1.3

—

Methotrexate

459

1401

3.44

122.85

1.4

1.1

—

Episodal and paroxysmal disorders

3175

10067

1.63

122.53

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3084

12433

1.62

122.51

1.3

—

Type 2 diabetes

2916

10414

1.65

122.46

1.3

—

Other nutritional deficiencies

2112

11191

1.76

122.26

1.3

—

Viral pneumonia

500

1631

3.24

120.37

1.4

1.3

—

Diabetes mellitus

3016

10898

1.63

119.53

1.3

—

Diabetes, varying definitions

3003

10892

1.63

119.22

1.3

—

Disorders of eyelid, lacrimal system and orbit

2693

12168

1.65

119.01

1.3

—

Bronchiectasis

373

1028

3.96

118.65

1.5

1.2

—

Diverticular disease of intestine

2197

7944

1.76

117.94

1.3

—

Mycoses

1007

4657

2.25

117.74

1.4

1.3

—

Other chronic obstructive pulmonary disease

1377

5772

2.01

117.23

1.3

1.2

—

Depression medications

721

1311

2.83

116.84

1.3

—

Urticaria

1010

4696

2.23

116.04

1.3

—

Pulmonary heart disease, diseases of pulmonary circulation

1110

5362

2.15

115.74

1.4

1.3

—

Sleep apnoea, including avohilmo

3024

11571

1.61

115.74

1.3

—

Fibrosis and cirrhosis of liver

377

1070

3.85

114.99

1.4

1.3

—

Diabetic nephropathy

705

2807

2.65

114.66

1.3

—

Hyperlipidaemia, other/unspecified

1286

5866

2.03

114.48

1.3

—

Abdominal and pelvic pain

2894

9032

1.64

114.10

1.3

—

Diseases of the eye and adnexa

2208

6406

1.76

113.23

1.3

—

Persons encountering health services for examination and investigation

1740

4699

1.89

112.91

1.3

1.2

—

DVT of lower extremities and pulmonary embolism

1377

7209

1.96

112.48

1.4

1.3

—

Iridocyclitis

823

3572

2.41

112.36

1.3

—

Unspecified haematuria

1419

6075

1.96

111.86

1.3

—

Other arrhythmias

1822

7688

1.81

111.25

1.3

—

Nausea and vomiting

907

3995

2.29

111.22

1.3

—

Pericarditis

213

399

6.04

111.10

1.4

1.3

—

Kidney transplant status

287

692

4.64

110.74

1.6

1.3

—

Diseases of the digestive system

1498

8072

1.89

110.48

1.3

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2920

12435

1.60

110.48

1.3

—

Exposure to unspecified factor

3074

13502

1.57

110.10

1.3

—

Polyarthrosis

693

2507

2.59

109.37

1.3

—

Cardiomyopathy

602

2285

2.76

109.24

1.2

1.3

—

Spondylosis

1683

7341

1.84

108.54

1.2

1.3

—

Cerebrovascular diseases

2281

9562

1.69

108.34

1.2

1.3

—

Insulin, intermediate and long-acting

1739

9573

1.80

108.13

1.3

—

Benign neoplasm of colon, rectum, anus and anal canal

2010

10054

1.73

107.40

1.3

—

Systemic lupus erythematosus, unspecified

197

359

6.41

106.73

1.4

1.2

—

Disorders of other endocrine glands

1398

7385

1.91

106.67

1.3

—

Genitourinary diseases

1604

4303

1.91

106.45

1.3

—

Asthma and allergy, excluding more controls

383

1128

3.48

105.43

1.4

1.3

—

Pure hypercholesterolaemia

2216

8464

1.70

105.02

1.3

—

Other disorders of urethra and urinary system

2111

8765

1.71

104.92

1.3

—

Paroxysmal tachycardia

637

2060

2.65

104.67

1.3

—

Other bacterial intestinal infections

670

2740

2.56

104.54

1.3

—

Pulmonary eosinophilia, not elsewhere classified

114

116

12.85

104.18

1.6

1.2

—

Seronegative rheumatoid arthritis

408

1289

3.34

103.65

1.3

1.2

—

Isolated proteinuria

194

359

6.33

103.51

1.4

1.2

—

Other bacterial intestinal infections, including avohilmo

821

3685

2.32

103.27

1.3

—

Asthma and allergy

383

1146

3.42

102.76

1.4

1.3

—

Chronic nephritic syndrome

230

496

5.28

102.54

1.6

1.2

—

Noninfectious colitis NAS

522

1908

2.89

102.51

1.5

1.3

—

Other CVD (FINNGEN)

389

873

3.57

102.44

1.3

1.2

—

Obesity and other hyperalimentation

1942

10880

1.71

102.42

1.3

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

547

2050

2.81

102.38

1.7

1.3

—

Obesity due to excess calories

1486

8255

1.85

101.84

1.3

—

Fungal Sepsis

238

531

5.02

101.33

1.5

1.2

—

Symptoms and signs concerning food and fluid intake

393

1228

3.37

101.23

1.3

—

Ethmoidectomy

516

1891

2.89

101.22

1.4

1.3

—

Obesity

1928

10835

1.71

101.09

1.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1880

10953

1.72

101.05

1.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2849

11639

1.57

100.40

1.3

—

Other/unspecified dorsalgia

1162

5924

1.99

99.75

1.3

—

Sciatica+with lumbago

1556

7763

1.81

99.28

1.2

1.3

—

FESS (DNB20)

502

1834

2.91

99.11

1.4

1.3

—

Visual disturbances and blindness

1649

9542

1.77

97.86

1.3

—

Insulin, fast-acting

1165

6077

1.98

97.48

1.3

—

Presence of cardiac and vascular implants and grafts

1387

5534

1.89

97.35

1.3

—

Implicit fungal Sepsis

223

488

5.14

97.33

1.5

1.2

—

Dorsopathies

2879

9407

1.57

97.25

1.3

—

Hypothyroidism, drug reimbursement

376

764

3.55

97.08

1.4

1.3

—

Scleritis

121

146

10.50

97.00

1.5

1.2

—

Enterocolitis due to Clostridium difficile

435

1489

3.10

96.77

1.4

1.2

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2703

13688

1.56

96.11

1.4

1.3

—

Other intervertebral disc disorders

2347

8707

1.63

95.98

1.3

—

Hyperkalaemia

284

751

4.12

95.86

1.3

—

Crohn's disease NAS

298

815

3.97

95.77

1.8

1.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2679

10235

1.58

94.66

1.3

—

Benign neoplasm: Colon

1707

9435

1.74

94.58

1.3

—

Liquid cancers

1023

4878

2.06

94.29

1.2

1.3

—

Hypertensive Renal Disease

198

401

5.48

94.24

1.3

—

Conduction disorders

907

3454

2.17

94.22

1.3

—

Type 2 diabetes, definitions combined

2686

10074

1.58

94.15

1.3

—

Streptococcal septicaemia, including avohilmo

358

1111

3.43

94.06

1.2

—

Pulmonary embolism

983

4907

2.07

93.82

1.4

1.3

—

Candidiasis, including avohilmo

990

4953

2.06

93.74

1.4

1.3

—

Disorders resulting from impaired renal tubular function

220

496

5.06

93.08

1.3

1.2

—

Migraine

1441

6251

1.83

92.97

1.3

—

Disorders of lens

1951

7268

1.70

92.79

1.3

—

Seropositive rheumatoid arthritis, wide

876

4217

2.16

92.50

1.4

1.3

—

Bacterial intestinal infections, IBD co-morbidities

664

2859

2.43

92.49

1.3

—

Type 2 diabetes, strict (exclude DM1)

2697

10168

1.57

92.42

1.3

—

Abnormal findings on examination of urine, without diagnosis

239

577

4.63

92.10

1.5

1.2

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

30.19

91.84

2.8

1.1

—

Other Crohn's disease

309

890

3.75

91.81

1.7

1.2

—

Pulmonary heart disease

983

4947

2.06

91.72

1.4

1.3

—

Osteoporosis with pathological fracture (FG)

272

717

4.06

91.58

1.5

1.2

—

Coxarthrosis [arthrosis of hip](FG)

1423

5423

1.84

91.47

1.2

—

Other ulcerative colitis

276

743

4.05

90.94

1.9

1.2

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

264

693

4.25

90.91

1.2

—

Streptococcal septicaemia

348

1084

3.41

90.90

1.3

1.2

—

Gonarthrosis [arthrosis of knee](FG)

1875

6413

1.71

90.63

1.2

—

Disorders of choroid and retina

2404

10767

1.59

90.61

1.3

—

Nasal polyp

663

2880

2.40

90.42

1.4

1.3

—

Other functional intestinal disorders

1380

7034

1.82

89.81

1.3

—

Dialysis

214

484

4.96

89.69

1.6

1.2

—

Other (seronegative) rheumatoid arthritis, wide

662

2894

2.39

89.17

1.4

1.3

—

ILD medications: pirfenidone

13.68

89.16

1.2

1.1

—

Care involving use of rehabilitation procedures

1853

10159

1.67

88.82

1.3

—

Insulin, fast-acting or short human

1169

6297

1.91

88.65

1.3

—

Other disorders of kidney and ureter

509

1983

2.72

88.65

1.3

—

Adalimumab

403

1391

3.08

88.43

1.5

1.3

—

L04AC Interleukin inhibitors

305

896

3.69

88.16

1.4

1.3

—

Other and unspecified urticaria

655

2866

2.38

87.68

1.3

—

Other antidepressants

2956

10031

1.53

87.60

1.3

—

Anterior Iridocyclitis

703

3174

2.31

87.57

1.3

—

Primary biliary cholangitis, wide definition

139

218

7.34

87.20

1.9

1.1

—

Other headache syndromes

1221

6674

1.87

87.03

1.4

1.3

—

Explicit bacterial Sepsis, including avohilmo

408

1429

3.01

86.81

1.3

1.2

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

845

4113

2.13

86.69

1.4

1.3

—

Visual disturbances

1512

8849

1.75

86.64

1.3

—

Intracranial trauma

1505

5810

1.78

86.55

1.3

—

Viral hepatitis, IBD co-morbidity

176

342

5.43

86.46

1.2

1.3

—

Acute and subacute iridocyclitis

662

2931

2.36

86.42

1.3

—

Sleep disorders (combined)

3139

11079

1.50

86.41

1.3

—

Other/unspecified seropositive rheumatoid arthritis

853

4185

2.11

85.62

1.4

1.3

—

Autoimmune hepatitis, wide definition

207

470

4.80

85.55

1.7

1.1

—

Any operation in hilmo

28.36

85.25

1.2

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

2653

10082

1.54

85.13

1.3

—

Pneumonia due to other infectious organisms, not elsewhere classified

176

353

5.57

84.95

1.8

1.2

—

Dizziness and giddiness

2215

11023

1.59

84.93

1.3

—

Explicit bacterial Sepsis

398

1392

3.02

84.92

1.3

1.2

—

Fibromyalgia

332

1049

3.34

84.43

1.4

1.3

—

Spinal stenosis

1506

6444

1.76

84.13

1.2

1.3

—

Mycoses, including avohilmo

2690

13693

1.52

83.85

1.3

—

Anaemia in chronic diseases classified elsewhere

159

298

6.20

83.61

1.3

—

Ischaemic heart disease, wide definition

2189

8552

1.61

83.46

1.3

—

Liquid cancers, including Hilmo

1174

5659

1.88

83.44

1.2

1.3

—

GI-bleeding

1030

5437

1.95

83.37

1.3

—

Shoulder lesions

2089

7849

1.62

83.03

1.3

—

Immunodeficiencies

239

623

4.24

82.86

1.5

1.2

—

Other coagulation defects

315

981

3.44

82.71

1.3

1.2

—

Other pleural conditions

396

1411

2.98

82.00

1.2

—

Other diseases of the digestive system

1027

5447

1.94

81.99

1.3

—

Other chronic obstructive pulmonary disease, including avohilmo

1635

8083

1.70

81.71

1.2

1.3

—

Asthma and opportunity respiratory infection

234

608

4.27

81.61

1.5

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

2860

11487

1.50

81.45

1.3

—

COPD, early/later onset

1386

6719

1.78

81.09

1.3

—

Presence of other functional implants

1735

7223

1.68

80.46

1.3

—

Other retinal disorders

1906

9064

1.63

80.21

1.3

—

Polyarteritis nodosa

16.41

80.11

1.8

1.1

—

Irritable bowel syndrome

839

4184

2.06

80.03

1.2

1.3

—

COPD, hospital admissions

1368

6670

1.77

79.52

1.2

1.3

—

Senile cataract

1761

6520

1.68

79.30

1.3

—

Factors influencing health status and contact with health services

768

1750

2.25

78.76

1.3

1.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

796

3932

2.10

78.58

1.2

1.3

—

Other peripheral vascular diseases

324

1059

3.26

78.35

1.3

1.2

—

Scleritis and episcleritis

272

802

3.66

78.15

1.4

1.2

—

Viral infections characterized by skin and mucous membrane lesions

1286

7406

1.78

77.86

1.4

1.3

—

Coronary atherosclerosis

1784

6921

1.66

77.81

1.3

—

Diabetes medication

2915

11644

1.48

77.37

1.3

—

Persons encountering health services in other circumstances

1202

6735

1.81

77.00

1.3

—

Any death

1868

8201

1.63

76.92

1.3

—

Reactive arthropathies, FINNGEN

254

720

3.75

76.88

1.4

1.2

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1702

10567

1.64

76.68

1.3

—

Major coronary heart disease event excluding revascularizations

1692

6828

1.67

76.25

1.3

—

Collagenous colitis

363

1285

3.00

76.24

1.4

1.2

—

Constipation

2573

11740

1.51

76.04

1.3

—

Idiopathic gout

384

1405

2.92

76.04

1.3

1.2

—

COPD, hospital admission 2, with asthma infections

1018

4713

1.92

76.02

1.3

—

Concussion

1294

5754

1.77

75.63

1.3

—

COPD related to multimorbidity

1211

5812

1.81

75.39

1.3

—

Other and unspecified coagulation defects

233

637

3.98

75.16

1.4

1.3

—

Other neurological diseases

2099

10585

1.56

75.10

1.3

—

Other diseases of urinary system

2749

10482

1.49

74.96

1.3

—

Other diseases of arteries and capillaries

345

1198

3.05

74.92

1.4

1.2

—

Polyarthritis, unspecified

177

396

4.92

74.84

1.5

1.2

—

Cellulitis

736

3595

2.12

74.78

1.3

—

Chorioretinal inflammation

167

360

5.26

74.52

1.4

1.2

—

Hypo-osmolality and hyponatraemia

580

2565

2.33

74.28

1.3

—

Mood disorders, excluding more controls

2639

10491

1.50

74.20

1.3

—

Vasomotor and allergic rhinitis

1045

5602

1.86

74.20

1.4

1.3

—

Amputation

387

1438

2.85

73.98

1.2

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1238

7169

1.77

73.71

1.3

—

Primary biliary cholangitis (PBC)

122

199

6.97

73.56

1.7

1.1

—

Dysphagia

785

3946

2.05

73.44

1.3

—

Use of hypnotics and sedatives

2996

11893

1.46

73.16

1.3

—

Hypersensitivity angiitis

19.62

73.10

3.0

1.1

—

Anxiety disorders, excluding more controls

2312

9797

1.53

72.72

1.3

—

Other gastritis (incl. Duodenitis)

712

3472

2.12

72.65

1.3

—

Arthrosis

1816

6206

1.63

72.30

1.2

1.3

—

Peripheral artery operations in Hilmo

443

1777

2.61

72.17

1.2

—

Hypokalaemia

427

1686

2.65

72.02

1.3

—

Peripheral arterial reconstruction

579

2631

2.30

71.20

1.2

—

Other medical care

1414

7141

1.70

70.89

1.2

1.3

—

Non-invasive ventilation

627

2502

2.21

70.69

1.3

—

Abnormal results of function studies

328

1145

3.03

70.50

1.4

1.2

—

Drug-induced osteoporosis with pathological fracture

124

218

6.87

70.45

1.6

1.3

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

865

3876

1.97

70.42

1.3

—

Fall on same level

3180

11956

1.44

70.36

1.3

—

Livedoid vasculitis

22.19

70.18

1.4

1.3

—

Lung cancer and mesothelioma

472

1642

2.51

70.12

1.2

—

Nonalcoholic fatty liver disease

387

1480

2.77

70.06

1.3

—

Lumbar disc prolapse

1768

8306

1.60

69.90

1.3

—

Pyoderma gangrenosum

11.88

69.65

1.5

1.3

—

Depression

2667

12303

1.47

69.48

1.3

—

Spondyloarthritis

529

2343

2.33

68.64

1.4

1.1

—

Myocardial infarction

1358

5654

1.72

68.54

1.3

—

Migraine without aura

573

2622

2.25

68.46

1.3

—

Mood [affective] disorders

2841

12752

1.45

67.57

1.3

—

Chronic gastritis

809

4235

1.97

67.33

1.3

—

Benzodiazepine use

2823

13368

1.44

67.33

1.3

—

Mood disorders

2845

12764

1.44

67.18

1.3

—

Spondylopathies (FG)

405

1609

2.61

67.08

1.4

1.2

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

517

2303

2.35

66.95

1.3

1.2

—

Other reaction to severe stress, and adjustment disorders

1017

5717

1.82

66.82

1.4

1.3

—

Other cataract

1252

5479

1.73

66.75

1.3

—

Diaphragmatic hernia

1083

6223

1.79

66.62

1.3

—

Other infectious diseases, including avohilmo

345

1277

2.86

66.61

1.3

1.2

—

Neurotic, stress-related and somatoform disorders

2459

11618

1.48

66.47

1.3

—

Disorders of mineral metabolism

322

1151

2.96

66.37

1.3

—

Pneumocystosis

131

256

6.06

66.28

1.6

1.3

—

Pneumocystosis, including avohilmo

131

256

6.06

66.28

1.6

1.2

—

Migraine with aura

693

3462

2.05

65.62

1.3

—

Zoster [herpes zoster], including avohilmo

1512

9162

1.62

65.48

1.4

1.3

—

Ischaemic Stroke, excluding all haemorrhages

1632

7603

1.61

65.47

1.2

1.3

—

Anxiety disorders

2476

11706

1.47

65.25

1.3

—

Cutaneous abscess, furuncle and carbuncle

801

4224

1.95

65.21

1.4

1.3

—

Urinary track infection

1485

4508

1.68

64.97

1.3

—

Chronic laryngitis and laryngotracheitis

458

1958

2.44

64.97

1.3

—

Other dialysis

168

407

4.66

64.87

1.5

1.2

—

445

1884

2.45

64.32

1.4

1.3

—

Other arthrosis

1364

5526

1.68

64.28

1.3

—

Stroke, including SAH

1802

8402

1.57

64.14

1.2

1.3

—

Raynaud syndrome

333

1235

2.85

64.06

1.3

—

Candidiasis

477

2089

2.38

64.06

1.4

1.3

—

Myocarditis

177

444

4.24

63.83

1.6

1.3

—

Drug-induced adrenocortical insufficiency

124

238

6.10

63.79

1.6

1.2

—

Immunodeficiency with predominantly antibody defects

148

329

5.09

63.69

1.5

1.2

—

Neoplasms

2005

6901

1.54

63.60

1.3

—

Stroke, excluding SAH

1720

8003

1.58

63.49

1.2

1.3

—

Other complications of surgical and medical care, not elsewhere classified

348

1324

2.76

63.48

1.3

—

Soft tissue disorders related to use, overuse and pressure

801

4265

1.93

63.20

1.3

—

Iron deficiency anaemia secondary to blood loss (chronic)

527

2425

2.26

62.75

1.3

—

Disorders of synovium and tendon

1427

7530

1.63

62.63

1.3

—

Subjective visual disturbances

784

4167

1.94

62.44

1.3

—

Adrenocortical insufficiency

184

488

4.16

62.44

1.6

1.2

—

Rheumatism, unspecified

415

1728

2.50

62.39

1.4

1.3

—

Endocarditis

162

390

4.53

62.33

1.3

1.2

—

Crohn's disease of large intestine

215

631

3.67

62.26

1.8

1.2

—

Other abnormal immunological findings in serum

118

220

6.09

62.11

1.4

1.3

—

Benign neoplasms

2654

10094

1.45

62.08

1.3

—

Volume depletion

335

1264

2.78

61.98

1.3

—

Other inflammatory liver diseases

265

888

3.19

61.70

1.6

1.3

—

AV-block

529

2067

2.25

61.61

1.3

1.2

—

Pacemaker

1086

5924

1.75

61.23

1.3

—

Other viral diseases, including avohilmo

1065

6163

1.75

61.23

1.4

1.3

—

Other (not insulin) diabetes medications

2646

10917

1.44

60.95

1.2

1.3

—

Other disorders of veins

1181

6997

1.70

60.86

1.3

—

Myositis

132

277

5.31

60.58

1.3

1.2

—

Cholelithiasis, broad definition with cholecystitis

2359

10876

1.46

60.29

1.4

1.3

—

Abnormalities of gait and mobility

433

1872

2.43

60.28

1.3

1.2

—

Other general symptoms and signs

186

498

3.92

60.25

1.3

—

Cystitis

2258

9191

1.48

60.13

1.3

—

Sequelae of external causes of morbidity and mortality

795

4304

1.90

59.87

1.3

—

Cirrhosis of liver, NAS

240

776

3.35

59.76

1.3

1.2

—

Coxarthrosis

1288

5038

1.68

59.73

1.2

1.3

—

Other diseases of biliary tract

325

1234

2.78

59.73

2.0

1.2

—

Gonarthrosis

1589

5701

1.60

59.28

1.2

1.3

—

Reactive arthropathies

293

1057

2.91

59.17

1.3

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1038

3963

1.77

59.15

1.3

1.2

—

Other viral diseases

835

4584

1.86

59.08

1.4

1.3

—

Disorders of the thyroid gland

2562

11726

1.43

58.90

1.3

—

Cardiomyopathies, Primary/intrinsic

378

1550

2.54

58.84

1.3

1.2

—

Protozoal diseases

162

411

4.43

58.82

1.6

1.2

—

Systemic sclerosis (FG)

113

212

5.92

58.76

1.2

1.1

—

Statin medication

1738

6355

1.56

58.75

1.3

—

Adjustment and management of implanted device

565

2739

2.14

58.74

1.2

1.3

—

Other disorders of adrenal gland

203

598

3.68

58.68

1.5

1.2

—

Amputation of toe

281

1002

2.99

58.52

1.2

—

Disorders of calcium metabolism

249

829

3.20

58.50

1.3

—

Psoriatic and enteropathic arthropathies

345

1362

2.63

58.07

1.3

1.2

—

Thrombotic microangiopathy

13.16

57.85

4.7

1.2

—

Chronic apical periodontitis

3052

12439

1.39

57.46

1.3

—

Disorders of parathyroid gland

629

3157

2.03

57.36

1.3

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

268

942

3.02

57.20

1.6

1.3

—

ILD medications: nintedanib

16.62

57.18

1.2

1.1

—

Protozoal diseases, including avohilmo

163

424

4.29

57.11

1.6

1.2

—

Unspecified nephritic syndrome

124

261

5.39

57.04

1.9

1.2

—

Crohn disease (strict definition, require KELA)

255

874

3.11

57.00

1.6

1.3

—

Cardiomyopathy (excluding other)

387

1628

2.47

56.95

1.3

1.2

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

319

1229

2.73

56.85

1.4

1.3

—

Crohn disease (strict definition, require KELA, min 2 HDR)

252

862

3.11

56.54

1.6

1.3

—

Any mental disorder

2951

10677

1.40

56.34

1.3

—

Somatoform disorder

498

2342

2.20

56.05

1.3

—

Secondary right heart disease

182

515

3.84

55.97

1.5

1.2

—

Calcific aortic valvular stenosis, including rheumatic fever

877

4791

1.81

55.87

1.3

—

Crohn's disease of small intestine

258

900

3.04

55.74

1.5

1.3

—

Calcific aortic valvular stenosis, operated

874

4780

1.81

55.70

1.3

—

Calcific aortic valvular stenosis

874

4780

1.81

55.70

1.3

—

Operations 2 for CAVS

873

4774

1.81

55.64

1.3

—

Calcific aortic valvular stenosis, diagnosis (helper)

873

4774

1.81

55.64

1.3

—

Other infectious diseases

280

1028

2.88

55.03

1.3

1.2

—

Exclusions for E4_PCOS_BROAD

537

2622

2.12

54.68

1.3

—

Rotator cuff syndrome

1621

7322

1.55

54.68

1.3

—

Early onset COPD

661

3475

1.96

54.66

1.3

—

Other pulmonary heart/vessel disease

192

574

3.61

54.19

1.6

1.2

—

Convulsions, not elsewhere classified

583

2895

2.03

54.14

1.2

1.3

—

6-mercaptopurine

126

277

4.86

53.98

1.5

1.1

—

COPD-related respiratory insufficiency

396

1729

2.40

53.83

1.2

—

Depression or dysthymia

1831

6697

1.51

53.54

1.3

—

Injuries to the head

3034

13247

1.37

53.42

1.3

—

Anxiety (asthma-related co-morbidities)

1616

8123

1.53

53.37

1.4

1.3

—

Total colectomy operation

182

532

3.71

53.31

1.7

1.2

—

Total colectomy

182

532

3.71

53.31

1.7

1.2

—

Seropositive rheumatoid arthritis, strict definition

471

2216

2.21

53.22

1.3

—

Hypothyroidism, other/unspecified

2346

10933

1.43

52.78

1.3

—

Nonischemic cardiomyopathy

338

1388

2.55

52.62

1.3

1.2

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2441

11421

1.42

52.52

1.3

—

Sequelae with surgical and medical care as external cause

633

3328

1.97

52.42

1.3

—

Crohn's disease (strict) with PSC

42.59

52.35

3.2

1.1

—

Other skin changes

619

3231

1.98

52.33

1.4

1.3

—

Other nonthrombocytopenic purpura

116

8.29

52.29

1.7

1.3

—

ILD and respiratory illness in diseases classified elsewhere

12.73

51.99

2.1

1.4

—

Ulcerative ileocolitis

171

488

3.79

51.87

2.1

1.2

—

Meniscus derangement

1353

5713

1.60

51.86

1.3

—

Open wound of lower leg

494

2389

2.14

51.84

1.3

—

Cholelithiasis

2220

10687

1.44

51.77

1.4

1.3

—

Adverse effects, not elsewhere classified

576

2945

2.02

51.59

1.2

1.3

—

Mixed connective tissue disease

172

6.25

51.59

1.6

1.1

—

Erythema nodosum

138

342

4.44

51.36

1.5

1.2

—

All anxiety disorders

1648

8570

1.51

51.27

1.3

—

Myocardial infarction, without ST-elevation

1138

6381

1.64

51.23

1.3

—

Internal derangement of knee

937

5498

1.72

51.12

1.3

—

Substance abuse, excluding more controls

1511

8344

1.54

50.95

1.2

1.3

—

Acute pancreatitis

589

3053

1.99

50.78

1.4

1.3

—

Other diseases of intestine

485

2347

2.14

50.78

1.3

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

8.76

50.63

1.2

—

Valvular operations

408

1848

2.28

50.46

1.3

—

All influenza (not pneumonia)

412

1874

2.27

50.31

1.4

1.3

—

Infection due to other mycobacteria, including avohilmo

181

6.01

49.98

1.4

1.2

—

Infection due to other mycobacteria

171

6.21

49.83

1.4

1.2

—

Disorders of muscles

320

1315

2.53

49.64

1.3

—

Functional dyspepsia

746

4192

1.82

49.61

1.4

1.3

—

Osteomyelitis

244

882

2.94

49.55

1.3

1.2

—

Chronic iridocyclitis

196

630

3.33

49.14

1.3

1.2

—

12.98

48.91

2.1

1.4

—

Atopic dermatitis, strict definition with reimbursement

768

4192

1.79

48.61

1.3

—

Drug-induced cataract

127

312

4.57

48.22

1.9

1.2

—

Other anxiety disorders

1218

6614

1.59

48.21

1.3

—

Exposure to other specified factors

2188

13466

1.41

48.21

1.3

—

Emphysema

256

964

2.80

47.86

1.3

1.2

—

Other/unspecified rheumatoid arthritis

384

1740

2.30

47.77

1.4

1.3

—

Diseases of the ear and mastoid process

3016

11261

1.36

47.53

1.3

—

Unspecified acute lower respiratory infection

476

2345

2.10

47.50

1.5

1.3

—

Angina pectoris

1439

6290

1.54

47.49

1.3

—

Chronic hepatitis, not elsewhere classified

151

422

3.89

47.41

1.9

1.2

—

Acquired haemolytic anaemia

122

294

4.62

47.34

1.4

1.2

—

Weight loss

346

1510

2.40

47.22

1.3

1.2

—

Migraine with aura and triptan purchases

451

2182

2.13

47.07

1.3

—

Polypectomy (DHB20)

247

924

2.84

47.04

1.5

1.2

—

Biguanides

2518

11098

1.38

46.95

1.2

1.3

—

Obesity, other/unspecified

910

5485

1.69

46.93

1.3

—

Nonsuppurative otitis media

631

2951

1.90

46.81

1.7

1.3

—

Disorders of skin appendages

1340

8798

1.54

46.78

1.4

1.3

—

Hernia

2469

11996

1.38

46.38

1.3

—

Other enthesopathies

780

4524

1.76

46.32

1.3

—

Myocardial infarction, strict

1186

5344

1.60

46.27

1.3

—

Cervicalgia

585

3121

1.92

46.11

1.3

—

Nonsuppurative otitis media, including avohilmo

851

4351

1.72

46.02

1.6

1.3

—

Gastroduodenal ulcer

716

4052

1.80

46.01

1.3

—

Pruritus

350

1549

2.34

45.92

1.4

1.3

—

Disorders of conjunctiva

2233

12523

1.40

45.76

1.3

—

Other viral diseases, not elsewhere classified, including avohilmo

735

4185

1.78

45.66

1.3

—

Other and unspecified drugs and medicaments

290

1188

2.56

45.64

1.4

1.2

—

Abnormal serum enzyme levels

870

5058

1.70

44.98

1.4

1.3

—

Abnormal weight loss

322

1393

2.42

44.92

1.3

1.2

—

Other and unspecified effects of external causes

757

4397

1.76

44.91

1.2

1.3

—

Ulcerative enterocolitis

134

358

4.07

44.87

1.9

1.2

—

COPD, hospital admissions 1, only main diagnosis

962

5090

1.66

44.78

1.2

1.3

—

Henoch-Schönlein purpura nephritis (HSPN)

14.78

44.73

1.6

1.3

—

Sequelae of cerebrovascular disease

1023

5462

1.63

44.68

1.2

1.3

—

Keratitis

978

6081

1.64

44.65

1.4

1.3

—

Personal history of allergy to drugs, medicaments and biological substances

125

6.94

44.58

1.3

1.4

—

Enteropathic arthropathies

106

240

4.84

44.30

1.6

1.2

—

Systemic sclerosis

113

270

4.62

44.24

1.2

1.1

—

Rash and other nonspecific skin eruption

310

1328

2.44

44.09

1.4

1.3

—

Cervical disc disorders

953

5906

1.65

44.08

1.3

—

Other symptoms and signs involving the digestive system and abdomen

472

2383

2.04

43.85

1.3

—

Allergic rhinitis

812

4773

1.71

43.79

1.4

1.3

—

Cardiomyopathy, other and unspecified

248

961

2.71

43.76

1.3

1.2

—

Persons encountering health services for specific procedures, not carried out

284

1177

2.52

43.43

1.3

—

Atopic dermatitis

1479

7998

1.49

43.33

1.3

—

Dermatitis due to substances taken internally

196

677

3.06

43.22

1.4

1.3

—

Other disorders of ear

2441

11638

1.37

43.19

1.3

—

Diseases of the myoneural junction and muscle

388

1839

2.19

43.17

1.3

—

Other and unspecified disorders of white blood cells

167

529

3.41

43.12

1.3

1.2

—

Other diseases of anus and rectum

817

4879

1.70

43.06

1.3

—

Oesophageal varices

171

550

3.35

43.05

1.5

1.2

—

Lung diseases due to external agents

424

2080

2.11

42.91

1.3

1.2

—

Other viral diseases, not elsewhere classified

518

2719

1.95

42.56

1.4

1.3

—

Kela reimbursement Agammaglobulinemia (D80-84)

7.94

42.52

1.7

1.4

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

2157

10529

1.39

42.33

1.3

—

Haemorrhage, not elsewhere classified

142

409

3.70

42.30

1.3

—

Other inflammation of eyelid

435

2170

2.07

42.07

1.4

1.3

—

Abnormal findings on diagnostic imaging of other body structures

410

2003

2.12

41.93

1.3

1.2

—

Falls/tendency to fall

2760

10369

1.35

41.71

1.3

—

Diseases of salivary glands

894

5536

1.65

41.63

1.3

—

Acute pancreatitis (for exclusion)

589

3262

1.86

41.47

1.4

1.3

—

Viral pneumonia (unknown virus, not influenza)

236

918

2.70

41.46

1.4

1.3

—

115

293

4.34

41.43

1.4

1.2

—

Other and unspecified iridocyclitis

180

609

3.15

41.34

1.3

1.2

—

Dermatopolymyositis (FG)

127

6.48

41.33

1.5

1.1

—

Covid-19 suspected case

584

3226

1.85

41.25

1.3

—

Other and unspecified immunodeficiencies with predominantly antibody defects

150

6.14

41.19

1.7

1.3

—

Recurrent aphthous stomatitis , including avohilmo

435

2192

2.05

40.91

1.4

1.3

—

Injuries to the knee and lower leg

3140

13031

1.31

40.88

1.3

—

Diabetic neuropathy

397

1937

2.14

40.76

1.3

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

855

5268

1.66

40.70

1.2

1.3

—

Glucagon-like peptide-1 (GLP-1) analogues

855

5268

1.66

40.70

1.2

1.3

—

Deforming dorsopathies

730

4313

1.73

40.63

1.2

1.3

—

Migraine without aura and triptan purchases

442

2243

2.02

40.47

1.3

—

Other and unspecified disorders of skin and subcutaneous tissue

215

809

2.80

40.42

1.3

1.2

—

Recurrent or chronic depression

1040

4593

1.60

40.35

1.3

—

Zoster [herpes zoster]

544

2976

1.88

39.89

1.5

1.3

—

Thrombocytopenia, unspecified

245

990

2.60

39.82

1.3

1.2

—

Diabetic retinopathy, excluding more controls

757

2478

1.76

39.63

1.3

—

Retention of urine

930

4722

1.62

39.51

1.3

—

Type 1 diabetes

659

3813

1.76

39.47

1.4

1.3

—

Conjunctivitis

1967

11531

1.39

39.19

1.3

—

Other/unspecified reactive arthropathies

228

898

2.68

39.17

1.4

1.2

—

Haemolytic anaemias

140

422

3.58

39.15

1.5

1.2

—

Symptoms and signs involving speech and voice

913

5771

1.61

39.10

1.3

—

Phlebitis and thrombophlebitis (not including DVT)

626

3590

1.79

39.09

1.4

1.3

—

Gastric ulcer

489

2601

1.93

39.06

1.3

—

Episcleritis

185

657

2.98

38.86

1.4

1.2

—

Generalized skin eruption due to drugs and medicaments

155

500

3.32

38.78

1.4

1.2

—

Chronic tubulo-interstitial nephritis

134

394

3.62

38.72

1.2

—

Acute generalized exanthematous pustulosis

174

603

3.08

38.41

1.4

1.3

—

Hyperparathyroidism

505

2702

1.90

38.25

1.3

—

Thyroiditis, ILD-related definition

305

1376

2.29

38.23

1.3

1.1

—

Papulosquamous disorders

1056

6934

1.55

38.14

1.3

—

Dermatophytosis

420

2145

2.03

38.13

1.4

1.3

—

Herpesviral [herpes simplex] infections

354

1700

2.16

38.05

1.4

1.3

—

Other symptoms and signs involving the circulatory and respiratory systems

205

774

2.76

38.05

1.4

1.3

—

Atypical mycobacterium lung infection

139

6.07

37.90

1.4

1.3

—

Arthropathies in other diseases classified elsewhere

135

406

3.56

37.77

1.4

1.3

—

Missing teeth due to accident, extraction or parodontitis

1661

10613

1.42

37.63

1.3

—

Childhood asthma (age<16), excluding more controls

267

874

2.43

37.27

1.3

—

Diabetic maculopathy, excluding more controls

320

1490

2.23

37.24

1.3

—

Ocular pain

272

1186

2.39

37.24

1.3

—

Elevated blood glucose level

265

1146

2.41

36.99

1.5

1.2

—

Problems related to lifestyle

309

1423

2.25

36.89

1.2

1.3

—

Other external causes of accidental injury

2011

7335

1.39

36.88

1.3

—

Dermatopolymyositis

149

5.65

36.87

1.5

1.2

—

Isolated proteinuria with specified morphological lesion

132

6.14

36.74

1.3

1.2

—

Childhood asthma (age<16)

268

888

2.40

36.45

1.3

—

Deviated nasal septum

841

5294

1.62

36.39

1.3

—

Disorders of optic nerve and visual pathways

290

1313

2.30

36.30

1.3

—

Aortic aneurysm

627

3598

1.75

36.29

1.2

1.3

—

Amputation of foot

117

332

3.86

36.14

1.2

1.3

—

Hypermobility syndrome

160

546

3.07

35.97

1.4

1.2

—

Selective serotonin reuptake inhibitors

2554

10077

1.33

35.95

1.3

—

Carpal tunnel syndrome

1557

9614

1.42

35.86

1.3

—

Misadventures to patients during surgical and medical care

421

2197

1.98

35.85

1.3

—

Pain in thoracic spine

414

2146

1.98

35.76

1.3

—

Decubitus ulcer and pressure area

204

796

2.69

35.65

1.2

—

Autoimmune hepatitis

7.44

35.64

2.1

1.1

—

Acute nephritic syndrome

250

4.32

35.29

1.7

1.2

—

Other disorders of eye and adnexa

410

2133

1.98

35.20

1.3

—

Other inflammation of eyelid, including avohilmo

1132

7663

1.50

35.13

1.3

—

Ulcerative rectosigmoiditis

254

1104

2.40

35.05

1.6

1.2

—

Special screening examination for infectious and parasitic diseases

524

2105

1.84

35.04

1.3

1.2

—

Suppurative and necrotic conditions of lower respiratory tract

196

759

2.73

34.96

1.4

1.3

—

Other and unspecified local infections of skin and subcutaneous tissue

303

1419

2.22

34.88

1.4

1.3

—

Herpesviral [herpes simplex] infections, including avohilmo

667

4013

1.70

34.87

1.3

—

Hepatic failure, not elsewhere classified

147

490

3.22

34.87

1.5

1.2

—

Hypoparathyroidism

141

460

3.29

34.71

1.4

1.2

—

Gout due to impairment of renal function

136

5.91

34.59

1.5

1.3

—

Substance abuse

1511

10033

1.42

34.58

1.2

1.3

—

Personal history of allergy to analgesic agent

8.48

34.48

1.4

1.1

—

Conjunctivitis (acute, non atopic), including avohilmo

2612

12127

1.31

34.44

1.3

—

Fracture of lumbar spine and pelvis

614

3622

1.73

34.35

1.3

—

Viral pneumonia (known virus, not influenza)

122

368

3.59

34.24

1.3

1.2

—

Non-selective monoamine reuptake inhibitors

951

5991

1.55

34.12

1.3

—

Personality disorders, excluding more controls

610

3593

1.72

34.10

1.3

—

Trochanteric bursitis

388

2001

1.99

34.09

1.2

1.3

—

Panniculitis, unspecified

101

6.64

34.06

1.4

1.1

—

Pyogenic arthritis

198

778

2.65

34.00

1.3

—

Enthesopathies of lower limb, excluding foot

592

3474

1.74

34.00

1.3

—

Substance use, excluding alcohol

532

3036

1.79

33.83

1.2

1.3

—

Type 1 diabetes, wide definition, subgroup 1

535

3057

1.79

33.67

1.4

1.3

—

Stomatitis and related lesions

550

3175

1.78

33.66

1.4

1.3

—

Systemic sclerosis, icd10

112

325

3.78

33.55

1.2

—

DVT of lower extremities

517

2939

1.80

33.41

1.3

—

Mental and behavioural disorders due to psychoactive substance use

1544

10207

1.40

33.29

1.2

1.3

—

Crystal arthropathies, rheuma endpoint

196

4.63

32.97

1.2

1.1

—

Cholecystitis

396

2083

1.96

32.89

1.4

1.3

—

Other local infections of skin and subcutaneous tissue

311

1505

2.14

32.87

1.4

1.3

—

Adult respiratory distress syndrome

130

5.70

32.80

1.3

—

Paralytic ileus and intestinal obstruction

663

4046

1.67

32.70

1.3

—

Transient ischemic attack

1343

7543

1.44

32.63

1.2

1.3

—

Conductive and sensorineural hearing loss

2036

10147

1.35

32.52

1.3

—

Allergic urticaria

245

1083

2.35

32.50

1.2

1.3

—

Injuries to the ankle and foot

1845

11722

1.36

32.48

1.3

—

Postviral fatigue syndrome

6.76

32.45

1.2

1.3

—

Abnormal involuntary movements

382

1997

1.97

32.41

1.3

—

Psychiatric diseases

2479

9519

1.32

32.33

1.3

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

603

3611

1.71

32.28

1.3

—

Diseases of oral cavity, salivary glands and jaws

1442

5239

1.43

32.20

1.2

1.3

—

Agranulocytosis

322

1592

2.10

32.15

1.3

—

Other CVD

559

3284

1.74

32.15

1.2

1.3

—

Drug-induced osteoporosis

169

5.05

32.03

1.9

1.2

—

Other or ill-defined heart diseases

163

599

2.84

31.97

1.3

—

Accidents

1971

7335

1.36

31.94

1.3

—

Other embolism and thrombosis

359

1847

2.00

31.93

1.3

—

Degeneration of macula and posterior pole

1251

6743

1.45

31.92

1.2

1.3

—

Disorders of oesophagus in diseases classified elsewhere

269

3.99

31.85

1.5

1.2

—

Algoneurodystrophy

121

379

3.41

31.80

1.3

1.2

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1063

7150

1.49

31.73

1.3

—

Other metabolic disorders

353

1808

2.01

31.70

1.4

1.3

—

Etanercept

208

868

2.51

31.59

1.2

1.3

—

Benign neoplasm: Colon, unspecified

690

4302

1.64

31.56

1.3

—

Disorders of orbit

153

551

2.94

31.48

1.5

1.2

—

Nonorganic sleeping disorders, excluding more controls

517

2988

1.77

31.37

1.3

—

Crohn disease (strict definition, all UC cases excluded)

171

653

2.75

31.34

1.5

1.2

—

Hydronephrosis

301

1463

2.12

31.32

1.2

—

Cardiodefibrillation

936

6238

1.53

31.29

1.3

—

Diseases of middle ear and mastoid

1442

8468

1.41

31.29

1.5

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

1448

9916

1.40

31.18

1.3

—

Pollen allergy

477

2665

1.80

30.98

1.5

1.4

—

Inflammatory diseases of female pelvic organs

1464

7202

1.41

30.95

1.3

—

Infective dermatitis

313

1552

2.08

30.92

1.2

1.3

—

Polyuria

610

3707

1.68

30.90

1.3

—

Other abnormalities of plasma proteins

190

4.63

30.89

1.4

1.3

—

Injuries to the thorax

1213

8531

1.44

30.81

1.2

1.3

—

Other keratitis

319

1596

2.06

30.73

1.4

1.3

—

Sensorineural hearing loss

1931

9675

1.34

30.67

1.3

—

Nonhereditary hypogammaglobulinemia

131

5.60

30.67

1.4

1.3

—

Other diseases of lip and oral mucosa

1088

7519

1.47

30.59

1.3

—

Other disorders of bone

506

2932

1.77

30.56

1.3

—

Coxibs

700

2245

1.66

30.39

1.3

1.4

—

Other disorders of optic [2nd] nerve and visual pathways

205

866

2.48

30.38

1.4

1.2

—

Voice disturbances

703

4442

1.62

30.35

1.3

—

Hypotension

492

2839

1.78

30.26

1.2

1.3

—

Benign neoplasm of other and ill-defined parts of digestive system

494

2861

1.77

30.08

1.4

1.3

—

Non-Hodgkin lymphoma, all, including Hilmo

380

2036

1.93

30.02

1.2

1.3

—

Abscess of lung

186

4.59

29.92

1.7

1.3

—

Infliximab

247

3.99

29.92

1.4

1.3

—

Conjunctivitis (acute, non atopic)

730

4645

1.59

29.88

1.3

—

Ankylosing spondylitis

251

1165

2.23

29.58

1.4

1.3

—

Other diseases of hard tissues of teeth

1411

5217

1.42

29.54

1.3

—

Dental operations

1536

5724

1.39

29.40

1.2

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

460

2548

1.80

29.31

1.2

1.3

—

Amyloidosis

270

3.81

29.25

1.1

1.3

—

Other immunodeficiencies

129

5.45

29.09

1.5

1.3

—

Asthma mixed form (mode), excluding more controls

116

371

3.23

29.01

1.3

1.2

—

Thoracic aortic aneurysm

406

2246

1.86

28.99

1.2

—

Other demyelinating diseases of the central nervous system

133

465

3.03

28.95

1.3

—

Speech therapy

683

4340

1.61

28.85

1.3

—

Type 1 diabetes, wide definition

546

3276

1.70

28.82

1.4

1.3

—

Diseases of pulp and periapical tissues, including avohilmo

2645

10749

1.28

28.76

1.3

—

Psoriasis

736

4764

1.57

28.60

1.3

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1583

10708

1.36

28.55

1.2

1.3

—

Discitis, unspecified

211

4.23

28.43

1.3

—

Arterial embolism and thrombosis

175

709

2.57

28.30

1.3

1.2

—

Other conditions related to polyarteritis nodosa

36.21

28.10

3.3

1.3

—

Alcohol use disorder, Swedish definition

1388

9207

1.39

28.08

1.2

1.3

—

Cerebral cysts

178

731

2.54

28.03

1.3

—

Diplopia

369

2002

1.90

28.03

1.3

—

Chronic pancreatitis

344

1826

1.94

27.99

1.2

—

External causes of morbidity and mortality

1554

5693

1.38

27.98

1.3

—

Adhesive capsulitis of shoulder

419

2363

1.82

27.88

1.4

1.3

—

Visual impairment including blindness (binocular or monocular)

207

911

2.36

27.86

1.2

—

Disorder of lipoprotein metabolism, unspecified

353

1892

1.92

27.82

1.2

1.3

—

Hepatomegaly and splenomegaly, not elsewhere classified

6.12

27.79

1.3

1.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

428

2356

1.81

27.74

1.3

—

Adult-onset Still disease

10.54

27.72

2.0

1.1

—

Pigmented purpuric dermatosis

135

5.25

27.67

1.2

1.3

—

Acute peritonitis

199

866

2.40

27.60

1.3

1.2

—

Other and unspecified myopathies

262

1273

2.14

27.56

1.2

1.3

—

Dilated cardiomyopathy

343

1831

1.94

27.55

1.2

—

Acute pharyngitis

377

2052

1.86

27.17

1.4

1.3

—

Generalized anxiety disorder

395

2200

1.83

27.16

1.5

1.3

—

Periodontitis

2528

12743

1.27

27.11

1.3

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

850

5738

1.51

27.07

1.3

—

Chronic periodontitis, including avohilmo

2523

12740

1.27

26.93

1.3

—

Other and unspecified tonsillitis

767

4186

1.54

26.93

1.3

—

Other crystal arthropathies

228

3.96

26.93

1.2

—

Aspergillosis, including avohilmo

123

5.49

26.85

1.6

1.3

—

Benign neoplasm: Transverse colon

321

1695

1.96

26.70

1.4

1.2

—

Caries of dentine, including avohilmo

1981

7745

1.32

26.56

1.3

—

Unspecified fall

1309

9391

1.38

26.55

1.3

—

Injury, poisoning and certain other consequences of external causes

1278

4574

1.41

26.54

1.3

—

Lupus nephritis

10.76

26.44

1.5

1.1

—

Dermatographic urticaria

196

862

2.36

26.44

1.3

1.2

—

Other diseases of pancreas

247

1193

2.15

26.43

1.3

1.2

—

Allergic bronchopulmonary aspergillosis (ABPA)

12.06

26.43

2.0

1.0

—

Cholecystectomy

1762

11403

1.33

26.42

1.3

—

Aspergillosis

121

5.49

26.38

1.6

1.4

—

Polycystic ovarian syndrome, consortium definition

1627

6971

1.35

26.30

1.3

—

Neuralgia and neuritis, unspecified

152

598

2.65

26.20

1.3

1.2

—

Persons with potential health hazards related to communicable diseases

881

5969

1.48

26.14

1.4

1.3

—

Abnormal findings on diagnostic imaging of central nervous system

157

629

2.61

26.14

1.4

1.2

—

Lichen simplex chronicus and prurigo

191

836

2.38

26.13

1.3

—

Cutaneous lupus erythematosus

286

3.54

26.08

1.3

1.2

—

Hypopituitarism

220

1021

2.24

26.08

1.2

1.3

—

Demyelinating diseases of the central nervous system

237

1132

2.17

26.04

1.3

—

1521

9899

1.35

26.04

1.2

1.3

—

Inflammatory diseases of the central nervous system

244

1181

2.14

25.95

1.3

—

Other enthesopathy of foot (+metatarsalgia)

267

1333

2.06

25.91

1.4

1.3

—

Chronic diseases of tonsils and adenoids

1791

8595

1.33

25.85

1.3

—

Other shoulder lesions

247

1200

2.12

25.83

1.2

1.3

—

Benign neoplasm: Sigmoid colon

512

3121

1.68

25.82

1.4

1.3

—

Juvenile arthritis (FINNGEN)

121

426

2.96

25.78

1.7

1.2

—

Psoriatic arthropathies

259

1284

2.08

25.66

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

621

3912

1.59

25.54

1.2

1.3

—

Later onset COPD

730

3859

1.55

25.51

1.2

1.3

—

Rosacea

343

1875

1.88

25.45

1.4

1.3

—

Other and unspecified rosacea

258

1286

2.07

25.31

1.4

1.3

—

Superficial injury of lower leg

662

4301

1.57

25.31

1.3

—

Artrosis, including avohilmo

2012

8514

1.30

25.29

1.2

1.3

—

Dental caries, including avohilmo

1832

7147

1.32

25.28

1.3

—

Amputation of ankle bones

272

3.57

25.28

1.4

1.2

—

Invasive ventilation

218

1022

2.22

25.26

1.3

1.2

—

Temporomandibular joint disorders, including avohilmo

1065

7345

1.42

25.24

1.4

1.3

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

312

1660

1.93

25.14

1.3

—

Acetic acid derivatives and related substances

669

2193

1.60

25.08

1.2

1.3

—

Open wound of ankle and foot

293

1533

1.97

24.96

1.3

—

Need for other prophylactic measures

181

791

2.39

24.94

1.3

1.2

—

Amyloidosis, other/unspecified

231

3.82

24.94

1.1

1.3

—

Phobic anxiety disorders

325

1750

1.89

24.93

1.3

1.4

—

Metatarsalgia

250

1237

2.08

24.91

1.3

—

Other encephalitis

107

362

3.16

24.88

1.3

1.2

—

Asthma mixed form (mode)

116

406

2.95

24.87

1.3

1.2

—

Haemorrhoids and perianal venous thrombosis

821

5558

1.49

24.78

1.3

—

Allergic contact dermatitis

329

1790

1.88

24.71

1.3

—

Localized swelling, mass and lump of skin and subcutaneous tissue

789

5347

1.50

24.69

1.4

1.3

—

Other follicular disorders

218

1031

2.19

24.63

1.4

1.3

—

Other localized connective tissue disorders

228

3.80

24.60

1.4

1.2

—

Cytomegalovirus infection, IBD co-morbidity

313

3.36

24.59

1.5

1.2

—

Selective deficiency of immunoglobulin G [IgG] subclasses

6.68

24.57

1.5

1.4

—

Panic disorder

353

1964

1.84

24.57

1.3

—

Oxicams

565

1974

1.65

24.55

1.3

—

Diseases of peritoneum

277

1431

2.00

24.54

1.3

1.2

—

Cardiac arrest

158

544

2.54

24.51

1.3

1.2

—

Excessive, frequent and irregular menstruation

853

3069

1.50

24.51

1.3

—

Unspecified privation

295

1557

1.95

24.50

1.2

1.3

—

Other bursopathies

336

1846

1.87

24.50

1.3

—

Cervicobrachial syndrome

528

3281

1.64

24.47

1.3

—

Pain and other conditions associated with female genital organs and menstrual cycle

478

2404

1.69

24.39

1.3

—

1441

9653

1.35

24.39

1.2

1.3

—

Other specified/unspecified inflammatory spondylopathies

140

550

2.65

24.24

1.4

1.3

—

Golimumab

119

432

2.91

24.20

1.3

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

10.12

24.11

1.6

1.2

—

Gingivitis and periodontal diseases

2494

10275

1.26

24.05

1.3

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1305

9272

1.36

23.98

1.3

—

Diseases of pulp and periapical tissues and dental caries

1634

6332

1.34

23.97

1.3

—

Diseases of spleen

228

3.78

23.93

1.3

—

Other diseases of blood and blood-forming organs

205

959

2.22

23.93

1.2

—

Vitreous haemorrhage

281

1472

1.97

23.92

1.2

1.3

—

Neuromuscular dysfunction of bladder

251

1265

2.05

23.89

1.2

1.3

—

Other and unspecified visual disturbances

293

1557

1.94

23.85

1.3

—

Relapsing polychondritis

12.37

23.80

1.3

1.6

—

Cytomegaloviral disease

319

3.28

23.79

1.5

1.2

—

Cytomegaloviral disease, including avohilmo

325

3.25

23.69

1.5

1.2

—

Bronchitis, not specified as acute or chronic

224

1086

2.12

23.63

1.5

1.2

—

Other disorders of nervous system

201

938

2.23

23.62

1.2

1.3

—

Restless leg syndrome

384

2222

1.77

23.58

1.3

—

Other juvenile arthritis

114

410

2.90

23.46

1.7

1.4

—

Fracture of rib(s), sternum and thoracic spine

792

5432

1.48

23.40

1.2

1.3

—

Pleural plaque

256

1313

2.01

23.22

1.2

—

Charcot foot

209

3.84

23.10

1.3

—

Encephalitis

108

383

3.00

23.07

1.3

1.2

—

Idiopathic thrombocytopenic purpura

106

372

3.03

23.06

1.3

1.2

—

Unstable angina pectoris

860

4689

1.46

22.96

1.3

—

Postprocedural disorders of nervous system

192

888

2.24

22.95

1.3

—

Vascular disorders of the intestines

197

921

2.22

22.94

1.3

—

Extreme obesity with alveolar hypoventilation

136

544

2.64

22.90

1.3

1.2

—

Other autoimmune haemolytic anaemias

152

4.47

22.89

1.3

—

Diseases of external ear

894

6296

1.44

22.88

1.4

1.3

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

270

1418

1.96

22.84

1.3

—

Unknown and unspecified causes of morbidity

163

706

2.38

22.69

1.3

—

Barrett oesophagus

158

681

2.43

22.56

1.3

1.2

—

Ankylosing spondylitis, ICD10

245

1251

2.02

22.54

1.4

1.3

—

Multiple myeloma and malignant plasma cell neoplasms

153

651

2.47

22.53

1.2

—

Multiple myeloma, including Hilmo

149

627

2.50

22.50

1.1

1.2

—

Alcoholic liver disease

277

1475

1.94

22.49

1.2

—

Lesion of ulnar nerve

356

2043

1.78

22.49

1.2

1.3

—

Thyrotoxicosis, other and/or unspecified

485

3017

1.64

22.48

1.3

—

Bipolar affective disorders

435

2632

1.68

22.47

1.2

1.3

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

526

1785

1.64

22.41

1.2

1.3

—

Fissure and fistula of anal and rectal regions

570

3686

1.57

22.32

1.3

—

Paracetamol or NSAID medication

361

1005

1.84

22.31

1.2

1.4

—

Idiopathic urticaria

258

3.44

22.25

1.4

1.2

—

Other extrapyramidal and movement disorders in other diseases

634

4204

1.54

22.24

1.2

1.3

—

Hypocalcemia

316

3.20

22.23

1.3

1.2

—

Use of pramipexole

556

3588

1.58

22.13

1.3

—

Tubulo-interstitial nephritis, not specified as acute or chronic

170

759

2.31

22.11

1.3

1.2

—

Disorders of vitreous body and globe

1290

9154

1.35

22.10

1.2

1.3

—

Cerebral palsy and other paralytic syndromes

291

1582

1.89

22.06

1.3

—

Other or unspecified ileus, impaction or obstruction

454

2791

1.66

22.05

1.3

—

Hernia of abdominal wall

1134

8366

1.37

21.98

1.3

—

Epilepsy

718

4872

1.49

21.95

1.3

—

Hypersensitivity pneumonitis due to organic dust

198

3.87

21.91

1.3

1.2

—

Vitamin deficiency, wide

147

621

2.47

21.90

1.3

—

Vitamin deficiency

147

621

2.47

21.90

1.3

—

Allergic conjunctivitis

1357

9877

1.33

21.89

1.3

—

Retinal vascular occlusion

321

1804

1.83

21.88

1.2

—

Other and unspecified nerve root and plexus disorders, also in other diseases

510

3236

1.61

21.79

1.2

1.3

—

Defects in the complement system

5.98

21.59

1.4

1.2

—

Papilloedema, unspecified

268

3.35

21.59

1.4

1.3

—

Olecranon bursitis

176

810

2.25

21.41

1.5

1.2

—

Other diseases of stomach and duodenum

183

857

2.21

21.31

1.2

1.3

—

Other disorders of patella

372

2191

1.73

21.29

1.3

—

Monoarthritis, not elsewhere classified

118

455

2.70

21.28

1.5

1.3

—

Viral and other specified intestinal infections, including avohilmo

637

4094

1.52

21.27

1.4

1.3

—

Disorders of vitreous body

1254

8981

1.34

21.07

1.2

1.3

—

Retinal vascular disorders

322

1832

1.80

21.06

1.2

—

Hypercalcemia

142

604

2.47

20.98

1.3

1.2

—

Ascites

205

1008

2.10

20.97

1.3

—

Intestinal stricture

771

5374

1.46

20.97

1.3

—

Respiratory tuberculosis, confirmed, including avohilmo

203

3.69

20.94

1.4

1.3

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

203

3.69

20.93

1.4

1.3

—

Other viral hepatitis, including avohilmo

186

883

2.18

20.92

1.2

1.3

—

Other forms of systemic lupus erythematosus

103

5.18

20.85

1.3

—

Respiratory tuberculosis, confirmed

194

3.76

20.85

1.4

1.3

—

Acute gastritis

195

943

2.13

20.84

1.3

—

Acute suppurative otitis media

595

3667

1.53

20.78

1.5

1.3

—

Other symptoms and signs involving cognitive functions and awareness

1164

7688

1.36

20.76

1.2

1.3

—

Myelodysplastic syndrome, including Hilmo

106

394

2.85

20.75

1.3

1.2

—

Amiodarone users

274

1494

1.89

20.75

1.2

—

Aortic valve malfunction, age under 60 years

258

1380

1.93

20.73

1.3

—

Psoriasis vulgaris

470

2966

1.62

20.65

1.3

—

Other noninfective disorders of lymphatic vessels and lymph nodes

119

470

2.66

20.59

1.3

1.2

—

Sub-endpoint used in defining T1D endpoints

683

4590

1.48

20.53

1.4

1.3

—

Benign neoplasm: Ascending colon

375

2244

1.71

20.50

1.3

—

Colectomy operation

429

2655

1.65

20.49

1.4

1.3

—

Dermatophytosis, including avohilmo

1609

12320

1.29

20.46

1.3

—

Nummular dermatitis

226

1161

2.01

20.46

1.4

1.3

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

272

1486

1.89

20.43

1.3

—

Suppurative and unspecified otitis media

828

5180

1.43

20.43

1.5

1.3

—

Menorrhagia

741

2819

1.48

20.38

1.3

—

Striking against or struck by other objects

822

5817

1.43

20.32

1.3

—

Other specified/unspecified soft tissue disorders

127

519

2.54

20.28

1.3

1.2

—

Arthropathy in ulcerative colitis

166

4.04

20.25

1.5

1.2

—

Injuries to the shoulder and upper arm

2138

13297

1.25

20.17

1.3

—

Other viral hepatitis

176

830

2.20

20.16

1.3

—

Gonarthrosis,primary

2193

10650

1.25

20.15

1.2

1.3

—

Chronic hepatitis NAS

153

4.17

20.11

1.7

1.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

612

4062

1.51

20.04

1.3

—

Other and unspecified haemorrhagic conditions

186

3.78

19.95

1.5

1.3

—

Intestinal malabsorption

139

598

2.43

19.94

1.3

—

Other/unspecified cytomegaloviral diseases

267

3.28

19.89

1.5

1.3

—

Irregular menses

1044

5761

1.37

19.87

1.3

—

Viral hepatitis, including avohilmo

210

1063

2.04

19.87

1.2

1.3

—

Tobacco use

162

745

2.26

19.85

1.2

1.3

—

Infections with a predominantly sexual mode of transmission

674

4615

1.48

19.82

1.4

1.3

—

Guillain-Barre syndrome

192

3.73

19.78

1.2

—

Prurigo nodularis

288

3.14

19.76

1.3

1.2

—

Benign neoplasm: Caecum

297

1687

1.81

19.67

1.3

1.2

—

Intracranial injury

1431

10314

1.30

19.62

1.3

—

Polymyositis

5.48

19.60

1.5

1.1

—

Other/unspecified enthesopathies, not elsewhere classified

208

1053

2.03

19.58

1.2

1.3

—

Personality disorders

610

4122

1.50

19.48

1.3

—

Chronic periodontitis, complicated

1397

10530

1.31

19.39

1.2

1.3

—

Other hammer toe(s) (acquired)

370

2026

1.69

19.29

1.2

1.3

—

Other aneurysm

154

702

2.28

19.26

1.4

1.2

—

Atopic dermatitis, strict definition

662

4458

1.47

19.08

1.3

—

Scoliosis

209

1070

2.00

19.05

1.2

1.3

—

Hallux valgus (acquired)

682

3349

1.47

19.00

1.3

—

Fitting and adjustment of other devices

866

5502

1.40

18.99

1.3

—

Hyperkinetic disorders, excluding more controls

266

1368

1.84

18.93

1.3

1.4

—

Diseases of tongue

168

797

2.18

18.93

1.3

—

Autoimmune hyperthyroidism

141

622

2.33

18.93

1.3

1.1

—

Osteonecrosis

179

872

2.13

18.92

1.3

1.2

—

Nonorganic sleeping disorders

517

3399

1.55

18.91

1.3

—

Mental and behavioural disorders due to tobacco

239

1286

1.92

18.89

1.2

1.3

—

Spirochaetal infections, other/unspecified

242

1308

1.91

18.88

1.3

—

Persistent mood disorders

448

2855

1.60

18.85

1.3

—

Other disorders of pigmentation

133

576

2.41

18.82

1.3

1.2

—

Other epidermal thickening

135

589

2.39

18.79

1.6

1.2

—

Non-follicular lymphoma

254

1396

1.88

18.79

1.2

—

Familial hypercholesterolemia

358

2164

1.69

18.77

1.2

1.3

—

Smoking dependency

239

1289

1.91

18.76

1.2

1.3

—

Viral hepatitis

197

996

2.04

18.74

1.2

1.3

—

Ovarian cyst

743

2956

1.45

18.61

1.3

—

Iridocyclitis in diseases classified elsewhere

230

3.36

18.57

1.3

1.2

—

Disorders of optic nerve, not elsewhere classified

268

3.16

18.44

1.3

1.2

—

Left bundle-branch block

181

892

2.09

18.41

1.3

1.2

—

Other disorders of bladder

305

1780

1.76

18.31

1.2

—

Transport accidents

1077

6719

1.35

18.27

1.3

—

Diabetic retinopathy

936

4244

1.39

18.27

1.2

1.3

—

Viral warts

251

1388

1.86

18.12

1.6

1.3

—

Abscess of anal and rectal regions

217

1146

1.94

18.10

1.3

—

Thyrotoxicosis

588

4008

1.49

18.07

1.3

—

Lesion of lateral popliteal nerve

141

637

2.30

18.07

1.5

1.3

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1126

8471

1.33

18.00

1.4

1.3

—

Poisoning by drugs, medicaments and biological substances

539

3612

1.51

18.00

1.3

—

Failure and rejection of transplanted organs and tissues

175

3.74

18.00

1.3

—

Pneumonia due to Streptococcus pneumoniae

111

452

2.55

17.94

1.3

1.2

—

Unspecified urinary incontinence

224

1200

1.92

17.92

1.3

—

Impingement syndrome of shoulder

530

3544

1.52

17.91

1.2

1.3

—

Specific personality disorders

525

3505

1.52

17.86

1.3

—

Radiculopathy

379

2354

1.64

17.83

1.2

1.3

—

Benign neoplasm: Stomach

249

1384

1.85

17.76

1.4

1.2

—

Triptan medication for migraine, min. 3 purchases

1241

7111

1.32

17.69

1.3

—

Other and unspecified diseases of blood and blood-forming organs

364

2.77

17.66

1.3

1.2

—

Multiple myeloma

388

2.70

17.56

1.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

388

2.70

17.56

1.2

—

N06DA Anticholinesterases

428

5066

0.64

17.54

1.2

1.3

—

Use of anticholinesterases

428

5066

0.64

17.54

1.2

1.3

—

Artificial opening status

149

697

2.22

17.52

1.4

1.2

—

Multifocal fibrosclerosis

6.25

17.51

1.2

1.1

—

Other erythematous conditions

111

459

2.54

17.50

1.4

1.2

—

Systemic disorders of connective tissue in diseases classified elsewhere

7.47

17.46

1.9

1.2

—

Corneal ulcer

440

2847

1.57

17.39

1.4

1.3

—

Congenital malformations of the urinary system, including avohilmo

168

825

2.11

17.39

1.2

1.3

—

conjunctival haemorrhage

207

1095

1.95

17.31

1.3

1.2

—

Trigger finger

332

2010

1.68

17.30

1.2

1.3

—

Vascular diseases of the intestine

114

479

2.48

17.29

1.3

1.2

—

Retinal detachments and breaks

849

6226

1.38

17.27

1.3

—

Injuries to the neck

547

3710

1.50

17.26

1.3

—

Secondary and unspecified malignant neoplasm of lymph nodes

227

1239

1.89

17.20

1.2

1.3

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

4.98

17.17

1.5

1.4

—

Ulcerative proctitis

162

788

2.12

17.16

1.4

1.2

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

111

464

2.50

17.09

1.5

1.2

—

Other renal tubulo-interstitial diseases

257

3.08

17.07

1.3

1.2

—

Cystic kidney disease, including avohilmo

109

453

2.53

17.04

1.2

—

Other abnormal uterine and vaginal bleeding

510

2430

1.53

17.04

1.3

—

Injuries to the elbow and forearm

1719

11845

1.25

16.99

1.3

—

Spontaneous rupture of synovium and tendon

199

1046

1.95

16.87

1.2

1.3

—

UC patients in KELA-register (code 208), prior to 1994

127

567

2.34

16.85

1.8

1.2

—

Other disorders of eyelid

1048

7503

1.33

16.77

1.2

1.3

—

Spondylolisthesis/Spondylolysis

422

2729

1.57

16.74

1.2

1.3

—

Congenital malformations of the urinary system

157

763

2.13

16.73

1.2

1.3

—

Erythema multiforme

283

2.96

16.68

1.7

1.2

—

Postprocedural disorders of digestive system, not elsewhere classified

101

409

2.59

16.66

1.3

1.2

—

Disorders of adult personality and behaviour

630

4419

1.44

16.63

1.3

—

Synovial cyst of popliteal space [Baker]

178

906

2.02

16.61

1.3

—

Superficial injury of head

581

4013

1.47

16.60

1.2

1.3

—

Rheumatoid lung disease

6.19

16.58

1.3

1.1

—

996

6760

1.34

16.54

1.3

—

Other and unspecified erythematous conditions

102

417

2.57

16.53

1.3

1.2

—

Perforation of tympanic membrane

247

1400

1.81

16.49

1.7

1.2

—

Malignant neoplasm, including Hilmo

2059

9802

1.23

16.47

1.3

—

Open wound of head

1331

9809

1.29

16.45

1.3

—

Other arterial embolism and thrombosis

318

2.80

16.45

1.3

—

Arthropathy in hypersensitivity reactions classified elsewhere

34.84

16.43

2.1

1.2

—

Seborrhoeic dermatitis

251

1431

1.80

16.42

1.4

1.3

—

Pneumothorax

177

904

2.02

16.40

1.4

1.2

—

Cystic kidney disease

102

419

2.56

16.39

1.2

—

Trigeminal neuralgia

152

735

2.13

16.38

1.2

—

Other/unspecified enthesopathies of lower limb, excluding foot

183

947

1.99

16.29

1.3

—

Mental and behavioural disorders due to alcohol

1207

8927

1.30

16.26

1.2

1.3

—

Unspecified chronic bronchitis

383

2.60

16.24

1.5

1.2

—

Calcinosis cutis

16.19

16.24

1.5

1.2

—

Brachial plexus disorders

219

1202

1.87

16.23

1.4

1.3

—

Respiratory conditions due to other external agents

266

3.01

16.21

1.3

1.2

—

Injuries to the wrist and hand

2478

13721

1.20

16.18

1.3

—

Intestinal adhesions without obstruction

214

1169

1.88

16.15

1.3

—

Sacroiliitis, not elsewhere classified

123

551

2.31

16.06

1.3

—

Viral and other specified intestinal infections

451

2909

1.53

16.04

1.4

1.3

—

Coxarthrosis, primary

1442

9501

1.27

16.03

1.2

1.3

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

399

2572

1.58

16.03

1.3

—

Injuries to the hip and thigh

1177

8183

1.30

15.94

1.3

—

Speech disturbances, not elsewhere classified

230

1291

1.83

15.91

1.3

1.2

—

Arthropathic psoriasis

279

1654

1.73

15.90

1.3

—

Post-traumatic stress disorder

184

960

1.96

15.89

1.3

—

Moderate visual impairment, binocular

359

2.65

15.85

1.2

—

Chronic inflammatory disorders of orbit

7.91

15.83

1.9

1.5

—

Umbilical hernia

652

4647

1.42

15.83

1.3

—

Status post-ami

581

3055

1.46

15.77

1.3

1.2

—

Malignant neoplasm, wide definition

2055

9827

1.23

15.67

1.3

—

Non-allergic asthma

209

1144

1.87

15.65

1.3

—

Cardiomyopathy in other diseases

5.94

15.63

1.1

1.3

—

Other/unspecified synovitis and tenosynovitis

260

1518

1.75

15.59

1.3

—

Extrapyramidal and movement disorders

924

6974

1.34

15.58

1.2

1.3

—

Pain associated with micturition

288

1731

1.70

15.55

1.2

1.3

—

Tuberculosis, IBD comorbidity

171

879

2.00

15.55

1.4

1.2

—

Other diseases of oesophagus

230

1300

1.81

15.51

1.3

—

Other disorders of conjunctiva

351

2219

1.62

15.50

1.3

—

Fentanyl

228

1281

1.81

15.50

1.2

1.3

—

Faecal incontinence

224

1257

1.83

15.49

1.3

—

CR(E)ST syndrome

198

3.32

15.45

1.1

1.2

—

Coeliac disease

285

1714

1.70

15.36

1.3

—

Fenamates

335

1404

1.65

15.36

1.3

1.4

—

Pyothorax

126

584

2.25

15.29

1.3

1.2

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

19.70

15.25

2.0

1.2

—

Malignant immunoproliferative diseases

126

4.03

15.24

1.1

1.2

—

Oesophagitis

146

716

2.11

15.23

1.3

1.2

—

Tuberculosis, wide, including avohilmo

180

949

1.95

15.21

1.4

1.2

—

Other degenerative diseases of the nervous system

591

3011

1.45

15.20

1.2

1.3

—

Dentofacial anomalies [including malocclusion]

1621

10248

1.25

15.19

1.3

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

259

2.95

15.14

1.4

1.3

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

737

5400

1.38

15.14

1.3

—

Other and unspecified acquired haemolytic anaemias

113

4.18

15.07

1.5

1.4

—

Acute posthaemorrhagic anaemia

404

2.50

15.06

1.4

1.3

—

Visual field defects

210

1167

1.85

15.06

1.3

1.2

—

Otitis externa

538

3740

1.46

15.04

1.4

1.3

—

Non-Hodgkin lymphoma, all

130

614

2.20

15.03

1.2

—

Disease of hard tissues of teeth, NOS

1249

5092

1.29

15.02

1.3

—

Artificial joint operation, meniscal resection

2190

11651

1.21

14.96

1.3

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1039

7941

1.31

14.95

1.2

1.3

—

Toxic liver disease

181

3.38

14.93

1.3

—

Unspecified misadventure during surgical and medical care

160

818

2.03

14.92

1.4

1.2

—

Hypertension, Pulmonary Arterial

4.74

14.91

1.1

1.2

—

Ehlers-Danlos syndrome, including avohilmo

132

3.82

14.86

1.2

—

Diseases of male genital organs

1211

4735

1.30

14.85

1.2

1.3

—

Unspecific neurodegenerative disorder

584

5614

0.70

14.83

1.2

1.3

—

Endometriosis

697

2909

1.41

14.82

1.3

—

Congenital malformations of the circulatory system

339

2086

1.61

14.75

1.3

—

Bullous disorders

154

780

2.04

14.73

1.3

1.2

—

Disorders of vestibular function (Vertigo)

1103

8363

1.30

14.72

1.3

—

Diabetic retinopathy, strict definition

449

2685

1.52

14.71

1.3

—

Other sleep disorders

265

1582

1.71

14.69

1.3

—

Pulmonary oedema

182

3.31

14.69

1.3

1.2

—

Hidradenitis suppurativa

104

452

2.39

14.68

1.2

—

Fracture of lower leg, including ankle

1292

10068

1.27

14.66

1.2

1.3

—

Postmenopausal osteoporosis with pathological fracture

165

857

1.99

14.66

1.3

1.2

—

Myeloproliferative diseases

208

1165

1.84

14.58

1.2

—

Acute laryngitis and tracheitis

256

1492

1.72

14.53

1.3

—

Cyst of kidney

187

1016

1.90

14.50

1.2

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

858

6386

1.34

14.49

1.3

—

Recurrent and persistent haematuria

112

4.14

14.46

1.5

1.2

—

Acute drug-induced interstitial lung disorder

4.58

14.43

1.3

—

Late syphilis

170

3.43

14.41

1.2

1.3

—

Insulin, fast-acting (human)

314

1967

1.62

14.37

1.4

1.3

—

Hodgkin lymphoma, hilmo

348

2.59

14.30

1.3

1.2

—

Poisoning by medicine

473

3240

1.48

14.29

1.3

—

Delirium, not induced by alcohol and other psychoactive substances

316

1983

1.62

14.29

1.3

1.2

—

Polycystic kidney disease

349

2.60

14.27

1.2

—

Congenital malformations of cardiac septa

169

863

1.95

14.26

1.1

1.3

—

Sequelae of other external causes

150

761

2.03

14.26

1.4

1.2

—

Alzheimer disease, including avohilmo

493

4892

0.69

14.16

1.2

1.3

—

Amenorrhoea

151

769

2.01

14.09

1.5

1.4

—

Skin changes due to chronic exposure to nonionizing radiation

930

6448

1.32

14.00

1.3

—

L01XE Protein kinase inhibitors

148

756

2.03

13.92

1.1

1.2

—

Pneumonia derived septicemia

101

445

2.37

13.89

1.3

1.2

—

Congenital malformations of the respiratory system, including avohilmo

232

2.97

13.88

1.7

1.3

—

Tuberculosis, wide

174

936

1.91

13.87

1.4

1.2

—

Type of accident

681

5002

1.38

13.83

1.3

—

Acquired absence of limb

125

3.84

13.80

1.3

—

Iron deficiency

353

2.53

13.79

1.3

—

Radial styloid tenosynovitis [de Quervain]

130

633

2.11

13.78

1.2

1.3

—

Arthropathy in Crohn disease

130

3.77

13.77

1.6

1.3

—

Atypical facial pain

130

635

2.11

13.74

1.4

1.2

—

Congenital malformations of trachea and bronchus

102

4.17

13.74

2.1

1.4

—

Pneumonitis due to solids and liquids

202

1142

1.81

13.69

1.3

1.2

—

Cramp and spasm

130

637

2.11

13.68

1.4

1.2

—

Coronary artery bypass grafting

559

2932

1.43

13.62

1.2

—

Amputation of thigh

350

2.53

13.58

1.2

—

Alzheimer disease

415

4349

0.67

13.54

1.2

1.3

—

Diffuse large B-cell lymphoma

143

729

2.04

13.54

1.2

—

Diffuse large B-cell lymphoma, including Hilmo

143

729

2.04

13.54

1.2

—

Diffuse large B-cell lymphoma, helper endpoint

143

729

2.04

13.54

1.2

—

Other acute viral hepatitis

156

3.45

13.54

1.3

1.4

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

621

4509

1.39

13.53

1.2

1.3

—

Arterial embolism and thrombosis of lower extremity artery

418

2.39

13.53

1.3

1.2

—

Viral warts, including avohilmo

492

3435

1.45

13.48

1.5

1.3

—

Lymphoid leukaemia

148

764

2.00

13.46

1.3

1.2

—

Vitamin D deficiency

236

2.91

13.46

1.2

1.3

—

704

4472

1.37

13.45

1.3

—

Cardiac murmurs and other cardiac sounds

196

1089

1.81

13.43

1.3

—

Secondary uncertain malignant neoplasm

324

2081

1.59

13.43

1.2

—

Alcohol use disorder, ICD-based

955

7398

1.30

13.38

1.2

1.3

—

Other condition

342

2225

1.57

13.37

1.3

—

Mononeuritis multiplex

12.60

13.37

1.4

1.8

—

Dissection of aorta

365

2.48

13.36

1.2

—

Drug-induced systemic lupus erythematosus

4.53

13.35

1.4

1.2

—

Dermatopolymyositis, unspecified

5.64

13.33

1.3

1.2

—

Other and unspecified follicular disorders

116

550

2.19

13.32

1.6

1.3

—

Late syphilis, including avohilmo

216

3.02

13.30

1.2

1.3

—

Bell's palsy

270

1665

1.65

13.27

1.3

—

Corns and callosities

165

887

1.91

13.24

1.4

1.2

—

Benign neoplasm: Adrenal gland

199

1134

1.81

13.23

1.3

—

Psoriatic arthropathies, ICD10

255

1553

1.68

13.23

1.3

—

Degenerative macular diseases

284

1776

1.63

13.22

1.2

1.3

—

MS-disease / Multiple Sclerosis

173

944

1.88

13.21

1.2

1.3

—

Xerosis cutis

211

3.02

13.21

1.5

1.2

—

Simple and mucopurulent chronic bronchitis

100

447

2.31

13.21

1.5

1.2

—

Actinic keratosis

899

6288

1.31

13.19

1.3

—

Other specified disorders of kidney and ureter

424

2.37

13.18

1.3

1.2

—

Benign neoplasm of other and unspecified endocrine glands

318

2044

1.59

13.17

1.3

—

Varicose veins

1372

8358

1.25

13.13

1.3

—

Other obstructive and reflux uropathy

104

474

2.26

13.12

1.1

1.2

—

Fracture of foot, except ankle

557

3996

1.41

13.09

1.4

1.3

—

Haemophagocytic lymphohistiocytosis

19.66

13.09

1.7

1.1

—

Right bundle-branch block

424

2.34

13.08

1.3

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

326

2.55

13.07

1.2

1.3

—

Otalgia

202

1159

1.78

13.04

1.4

1.3

—

Background retinopathy and retinal vascular changes

269

2.75

13.01

1.2

1.3

—

Gangrene, not elsewhere classified

4.44

12.96

1.3

1.4

—

Other retinal artery occlusion

299

2.64

12.94

1.2

—

Otitis externa, unspecified

273

1700

1.64

12.93

1.4

1.3

—

Heart failure and hypertrophic cardiomyopathy

248

2.84

12.90

1.3

1.2

—

Pleural plaque with presence of asbestos

192

1092

1.81

12.90

1.2

—

Nail disorders

205

1188

1.77

12.80

1.2

1.3

—

Myelodysplastic syndrome

141

3.49

12.78

1.1

1.3

—

Certolizumab pegol

187

3.09

12.78

1.3

—

Exclusions for E4_PCOS_CONSORTIUM

1584

8095

1.23

12.76

1.3

—

Morphin

254

2.76

12.73

1.2

1.3

—

Alzheimer’s disease, strict definition

294

3670

0.64

12.72

1.3

—

511

3387

1.43

12.67

1.2

1.3

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

191

1089

1.80

12.67

1.2

—

Congenital malformations of the respiratory system

216

2.95

12.67

1.8

1.3

—

Agoraphobia

349

2.46

12.65

1.3

1.4

—

Diseases of inner ear

1264

9747

1.25

12.62

1.3

—

KRA_PSY_EATING, excluding more controls

154

812

1.91

12.58

1.2

1.3

—

Other symptoms and signs involving the urinary system

249

1528

1.66

12.54

1.3

—

Cryoglobulinemia

16.98

12.51

1.3

1.1

—

Ulcer of oesophagus

165

904

1.88

12.49

1.3

1.2

—

Disorders of continuity of bone

230

1384

1.70

12.48

1.4

1.3

—

Benign neoplasm: Rectum

431

2985

1.47

12.48

1.3

—

Tongue abnormality

156

841

1.91

12.48

1.3

1.2

—

Fibroblastic disorders

498

3536

1.43

12.45

1.2

—

Hyperhidrosis

285

2.60

12.44

1.3

—

Neovascular glaucoma

110

526

2.17

12.39

1.4

1.2

—

Myeloproliferative diseases (CML excluded)

185

1053

1.80

12.37

1.2

—

Septal defects

152

797

1.92

12.33

1.1

1.3

—

Sulfonylureas

751

4507

1.34

12.32

1.2

1.3

—

Exophthalmic conditions

115

3.75

12.30

1.3

1.4

—

Unspecified/other endometriosis

194

1094

1.77

12.29

1.4

—

Use of other anti-dementia drugs

336

4039

0.66

12.28

1.2

1.3

—

Use of memantine

336

4039

0.66

12.28

1.2

1.3

—

Mixed hyperlipidaemia

103

482

2.21

12.25

1.3

1.2

—

Autonomic disorders

295

2.59

12.23

1.3

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

164

886

1.86

12.19

1.2

1.4

—

Colonic or urogenital fistula

611

4507

1.37

12.18

1.3

—

Superficial injury of ankle and foot

283

1803

1.60

12.16

1.3

—

Lateral epicondylitis

281

1787

1.60

12.16

1.3

—

Primary hyperparathyroidism

258

1611

1.64

12.15

1.3

—

Calculus of kidney and ureter

690

5190

1.35

12.09

1.3

—

Other diseases of spinal cord

364

2.41

12.06

1.3

—

Benign neoplasm: Descending colon

182

1040

1.80

12.05

1.2

—

Explicit fungal Sepsis

4.41

12.05

1.3

1.2

—

Tuberculosis

143

757

1.94

12.04

1.4

1.2

—

Explicit fungal Sepsis, including avohilmo

4.41

12.04

1.3

1.2

—

Superficial injury of wrist and hand

466

3292

1.43

12.03

1.3

—

Other disorders of the musculoskeletal system and connective tissue

344

2296

1.53

12.02

1.4

1.3

—

Ehlers-Danlos syndrome

112

3.75

12.01

1.2

1.3

—

Other specified and unspecified retinal disorders

461

2.23

11.98

1.6

1.3

—

Duodenal ulcer

248

1538

1.64

11.97

1.2

—

Pneumococcal septicemia

442

2.26

11.96

1.3

1.2

—

Open wound of forearm

233

1425

1.67

11.92

1.4

1.3

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

104

3.94

11.90

1.0

1.3

—

Unspecified jaundice

121

608

2.05

11.88

1.5

1.2

—

Granulomatous disorders of skin and subcutaneous tissue

305

2.53

11.87

1.2

—

Congenital malformations of heart and great arteries

292

1828

1.58

11.86

1.3

—

Other and unspecified disorders of orbit

5.08

11.85

1.6

1.4

—

Benign thyroid growths and nodules

702

4924

1.34

11.84

1.3

—

Injuries to unspecified part of trunk, limb or body region

246

1528

1.64

11.83

1.3

—

Cervicocranial syndrome

238

1465

1.65

11.83

1.3

—

Acute myeloid leukaemia and myelodysplastic syndromes

294

2.57

11.82

1.2

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

353

2376

1.51

11.78

1.2

1.3

—

Syphilis

325

2.48

11.77

1.2

1.3

—

Syphilis, including avohilmo

325

2.48

11.77

1.2

1.3

—

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

191

2.97

11.74

1.1

1.3

—

Carrier of infectious disease

320

2.49

11.69

1.7

1.3

—

Urolithiasis

740

5650

1.32

11.68

1.3

—

Malignant neoplasm

1958

9656

1.19

11.66

1.2

1.3

—

Other psoriatic arthropathies

242

1505

1.64

11.61

1.3

—

Flat foot [pes planus] (acquired)

202

1199

1.72

11.56

1.3

—

Triptan medication for migraine, single purchase ok

1688

9529

1.21

11.53

1.3

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1688

9529

1.21

11.53

1.3

—

Hypogonadotropic hypogonadism

423

2.27

11.53

1.2

1.3

—

Benign neoplasm of mouth and pharynx

250

1571

1.62

11.49

1.3

—

Malignant neoplasm

1957

9665

1.19

11.48

1.2

1.3

—

Lung transplant status

107

3.83

11.44

1.3

1.4

—

Lung transplantation

107

3.83

11.43

1.3

1.4

—

Ventral hernia

546

3999

1.38

11.43

1.3

—

Vitamin B12 deficiency anaemia

229

1409

1.66

11.43

1.3

1.2

—

Other or unspecified immunodeficiency

5.55

11.42

1.8

1.4

—

Glaucoma secondary to other eye disorders

110

543

2.10

11.42

1.4

1.2

—

Chronic viral hepatitis

130

680

1.97

11.41

1.2

1.3

—

Degenerative diseases of the nervous system

498

4930

0.72

11.38

1.2

1.3

—

Presence of other devices

539

3878

1.38

11.34

1.2

1.3

—

Cluster headache, strict

432

2.22

11.29

1.3

—

Folate deficiency anaemia

122

3.53

11.28

1.4

1.3

—

Suicide or other Intentional self-harm

515

3744

1.39

11.26

1.2

1.3

—

Secondary thrombocytopenia

153

3.22

11.26

1.2

1.3

—

Abnormal blood-pressure reading, without diagnosis

107

525

2.09

11.23

1.6

1.3

—

Other chondrocalcinosis

159

3.17

11.18

1.2

—

Sudden idiopathic hearing loss

239

1498

1.63

11.13

1.3

—

Other salmonella infections, including avohilmo

109

542

2.07

11.08

1.4

1.3

—

Postzoster neuralgia

198

2.89

11.06

2.1

1.2

—

Cluster headache, wide

462

2.17

11.05

1.3

—

Dislocation, sprain and strain of joints and ligaments at neck level

334

2254

1.50

11.05

1.3

—

Other specified/unspecified bacterial intestinal infections

161

911

1.81

11.03

1.2

1.3

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

161

910

1.80

10.97

1.1

1.3

—

Mental and behavioural disorders due to opioids

457

2.17

10.96

1.2

1.4

—

Other disorders of glucose regulation and pancreatic internal secretion

198

1188

1.70

10.96

1.3

—

Chronic conjunctivitis

367

2.32

10.96

1.4

1.2

—

Familial hypercholesterolemia, with ischemic heart disease

216

1327

1.66

10.93

1.2

—

Other salmonella infections

445

2.19

10.92

1.3

1.2

—

Other superficial mycoses

287

2.51

10.91

1.4

1.3

—

Benign neoplasm: Rectum, anus and anal canal

465

3347

1.41

10.90

1.3

—

Other and unspecified vascular occlusions

218

1345

1.66

10.83

1.2

1.3

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

433

2.19

10.82

1.3

—

Optic neuritis

107

534

2.07

10.80

1.3

—

Hypertrophic cardiomyopathy

114

583

2.03

10.79

1.3

1.2

—

Other problems related to primary support group, including family circumstances

238

1457

1.62

10.78

1.4

1.3

—

Infections with a predominantly sexual mode of transmission, including avohilmo

820

5855

1.29

10.76

1.4

1.3

—

Social phobias

177

1035

1.74

10.69

1.4

—

Other blood glucose lowering drugs, excl. Insulins

349

2395

1.48

10.66

1.2

1.3

—

Behavioural syndromes associated with physiological disturbances and physical factors

2203

12802

1.17

10.58

1.3

—

Ganglion

415

2941

1.43

10.56

1.2

1.3

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

3.99

10.55

1.2

1.3

—

Primary coxarthrosis, bilateral

655

4993

1.33

10.54

1.2

1.3

—

Traumatic subdural haemorrhage

286

1762

1.54

10.53

1.2

1.3

—

Chondropathies

329

2237

1.49

10.53

1.3

—

Pemphigoid

349

2.33

10.48

1.3

1.2

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

459

2.14

10.47

1.4

1.3

—

Erythema intertrigo

318

2.40

10.44

1.4

1.2

—

Paralytic ileus

453

2.14

10.43

1.5

1.2

—

Diabetic maculopathy

313

1995

1.51

10.42

1.3

—

Cerebral arteritis

9.08

10.42

1.5

—

Other female pelvic inflammatory diseases

327

2227

1.49

10.38

1.3

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

509

3748

1.38

10.38

1.3

—

Common variable immunodeficiency

4.35

10.38

1.4

1.5

—

Other/unspecified crystal arthropathies

4.05

10.37

1.2

—

Primary gonarthrosis, bilateral

1193

8167

1.23

10.36

1.2

1.3

—

Other and unspecified disorders of vitreous body

961

7527

1.26

10.34

1.2

1.3

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Neutrophil cytoplasmic Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS